data_1e5c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e5c _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.263 0.554 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 34.4 m -121.94 84.3 2.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.271 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.526 HG22 ' CG2' ' A' ' 277' ' ' VAL . 3.5 p -79.96 149.2 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 268' ' ' SER . 0.0 OUTLIER -131.48 164.1 26.5 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.63 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -120.01 162.74 18.72 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.399 -0.813 . . . . 0.0 109.899 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.503 HG23 ' N ' ' A' ' 255' ' ' ARG . 15.8 m -169.64 161.69 9.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.252 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.503 ' N ' HG23 ' A' ' 254' ' ' THR . 0.6 OUTLIER -106.69 119.71 40.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.506 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 264' ' ' ASN . . . -97.68 -89.84 0.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.829 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 264' ' ' ASN . 2.8 mt-10 -91.75 168.63 11.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.764 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 9.0 tt0 -170.29 148.85 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -157.27 -168.93 2.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.478 -0.764 . . . . 0.0 108.957 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t -84.71 46.05 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.113 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -160.22 -36.33 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.493 ' HA3' ' HG3' ' A' ' 319' ' ' LYS . . . -172.63 171.6 44.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.567 ' CE1' ' HB ' ' A' ' 317' ' ' VAL . 5.9 p90 -134.66 137.2 43.4 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.047 -1.267 . . . . 0.0 109.84 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.479 ' O ' ' HB1' ' A' ' 256' ' ' ALA . 77.5 m-20 -79.09 102.16 8.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.583 HG12 ' CE1' ' A' ' 267' ' ' TYR . 4.3 t -78.19 150.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.311 -0.868 . . . . 0.0 108.982 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.539 ' N ' HG11 ' A' ' 265' ' ' VAL . 15.2 p -133.5 93.43 3.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.662 ' CD1' ' CZ ' ' A' ' 313' ' ' PHE . 48.8 m-85 -81.32 132.4 35.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 252' ' ' THR . 6.5 m -111.06 119.63 39.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.015 -1.053 . . . . 0.0 110.319 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.488 HG13 ' CD1' ' A' ' 275' ' ' TRP . 71.7 t -97.93 138.01 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.399 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.458 ' N ' HG11 ' A' ' 269' ' ' VAL . 14.8 m -149.49 130.38 14.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 132.1 -37.31 2.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.2 m -150.89 159.85 44.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -97.17 -44.57 6.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 108.995 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -80.22 77.41 6.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 108.834 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.488 ' CD1' HG13 ' A' ' 269' ' ' VAL . 60.0 p-90 -123.75 165.39 17.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 109.544 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 330' ' ' CYS . 86.5 m -135.98 118.19 15.55 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.144 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.526 ' CG2' HG22 ' A' ' 251' ' ' VAL . 44.8 t -105.16 104.48 17.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.67 109.36 8.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 108.96 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.431 HD13 ' CE1' ' A' ' 313' ' ' PHE . 11.8 mt -79.93 145.97 32.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.65 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.7 96.14 3.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 287' ' ' ILE . 3.9 mm? -59.89 169.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.51 ' ND2' HG21 ' A' ' 324' ' ' THR . 0.7 OUTLIER -115.57 148.54 39.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.26 -143.61 40.93 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.5 p -84.13 7.94 17.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.598 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.481 ' C ' ' CG2' ' A' ' 286' ' ' THR . 61.8 mt-30 -44.26 167.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -155.89 174.89 14.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.541 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.518 ' CD1' HD22 ' A' ' 281' ' ' LEU . 13.9 mm -98.59 109.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.465 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 0.3 OUTLIER -85.56 -34.23 21.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -165.45 171.36 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 109.831 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.531 ' CB ' ' CG1' ' A' ' 315' ' ' VAL . 43.5 p -161.86 169.98 20.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.347 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 32.1 p90 -169.99 165.91 9.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.3 m-20 71.79 3.42 4.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 109.68 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . -174.42 145.66 0.99 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.49 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.65 101.25 12.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.423 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.519 ' CG2' HG21 ' A' ' 304' ' ' VAL . 3.4 p -116.96 141.84 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.583 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' THR . . . . . 0.418 ' C ' ' HG2' ' A' ' 302' ' ' ARG . 19.4 p . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 121.274 0.559 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . 0.418 ' HG2' ' C ' ' A' ' 301' ' ' THR . 4.2 mmt180 -139.03 132.24 29.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 295' ' ' VAL . 41.3 m -76.29 118.63 19.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.952 . . . . 0.0 109.503 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.519 HG21 ' CG2' ' A' ' 295' ' ' VAL . 75.6 t -101.59 149.35 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.2 p -146.15 148.36 34.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.336 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.438 ' HB3' ' CE2' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -77.91 138.64 16.79 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.588 2.192 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.98 -17.91 51.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.13 -37.15 1.43 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.21 11.06 3.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.129 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -109.93 65.14 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 7.1 m120 -58.63 -28.32 65.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -1.163 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 267' ' ' TYR . 88.6 m -102.01 125.58 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.662 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 7.0 p90 -111.47 171.46 7.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 265' ' ' VAL . . . -151.34 128.68 2.64 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 290' ' ' SER . 17.9 m -133.83 158.19 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.58 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.2 m -88.87 109.22 20.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 263' ' ' PHE . 25.2 t -79.5 106.6 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 1.1 mmt -59.31 94.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.125 -0.985 . . . . 0.0 108.75 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . 0.528 ' HD3' ' CB ' ' A' ' 323' ' ' SER . 21.2 mttt -41.07 -45.29 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.718 . . . . 0.0 109.775 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 319' ' ' LYS . 55.0 m-20 41.06 45.4 2.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.511 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.61 29.96 28.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 319' ' ' LYS . 29.0 t -160.05 110.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -1.15 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.528 ' CB ' ' HD3' ' A' ' 319' ' ' LYS . 11.5 p -98.93 25.44 6.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.69 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' THR . . . . . 0.51 HG21 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.92 145.72 24.5 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.113 -0.992 . . . . 0.0 109.572 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.595 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 16.3 m -71.14 146.47 92.52 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.595 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 24.9 Cg_endo -73.42 173.37 13.92 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.169 1.913 . . . . 0.0 110.761 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.65 149.25 24.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.58 ' HB1' ' CE2' ' A' ' 267' ' ' TYR . . . -142.43 132.89 25.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.079 -1.013 . . . . 0.0 109.864 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -128.74 156.63 43.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.494 -0.753 . . . . 0.0 109.29 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . 0.478 ' HB2' HG13 ' A' ' 251' ' ' VAL . 22.8 t -131.87 162.84 29.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.96 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.13 179.85 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 9.6 p . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.363 0.601 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.82 81.16 1.62 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.525 HG23 ' CG2' ' A' ' 277' ' ' VAL . 7.3 p -79.58 149.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.88 171.39 14.47 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -127.99 164.91 21.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -168.55 107.06 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.436 ' HG2' ' OG1' ' A' ' 325' ' ' THR . 1.3 mmm180 -48.97 123.39 7.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 264' ' ' ASN . . . -105.41 -90.38 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.706 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 4.3 mm-40 -88.03 165.62 15.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 109.549 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 84.6 tt0 -170.35 155.82 5.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . 0.439 ' O ' ' HE3' ' A' ' 319' ' ' LYS . 11.7 p90 -163.01 -168.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 t -84.34 43.33 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.2 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 319' ' ' LYS . 3.1 t70 -155.68 -38.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.783 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.457 ' O ' ' HE3' ' A' ' 319' ' ' LYS . . . -167.92 -169.08 30.96 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 31.9 p90 -152.21 128.67 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -1.235 . . . . 0.0 109.894 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.488 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 10.0 t30 -79.59 113.18 17.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.82 . . . . 0.0 109.608 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.619 ' CG1' ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -92.09 148.16 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 0.0 109.111 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.531 ' N ' HG11 ' A' ' 265' ' ' VAL . 23.1 p -126.77 95.36 4.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.354 -0.841 . . . . 0.0 109.246 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.653 ' CD1' ' CZ ' ' A' ' 313' ' ' PHE . 42.4 m-85 -80.99 130.84 35.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 108.765 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.453 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.3 p -109.17 119.55 39.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.082 -1.012 . . . . 0.0 110.022 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.585 HG12 ' CD1' ' A' ' 275' ' ' TRP . 79.2 t -92.85 135.62 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.52 116.08 7.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 149.12 -39.17 0.94 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.12 168.58 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -1.118 . . . . 0.0 109.42 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -42.13 7.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.891 . . . . 0.0 109.23 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.64 71.41 10.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 108.868 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.585 ' CD1' HG12 ' A' ' 269' ' ' VAL . 56.7 p-90 -115.81 172.4 7.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 0.0 109.656 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 83.6 m -141.36 108.54 5.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.313 -0.867 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.578 HG21 ' CE3' ' A' ' 275' ' ' TRP . 46.7 t -91.63 103.29 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.354 -0.841 . . . . 0.0 109.906 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.17 111.23 8.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 108.904 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.513 ' CD2' HG13 ' A' ' 277' ' ' VAL . 3.9 mm? -80.09 145.93 32.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.845 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.81 92.53 2.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.221 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.518 ' CD1' HG12 ' A' ' 317' ' ' VAL . 3.9 mm? -59.93 165.62 3.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.567 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.523 ' ND2' HG21 ' A' ' 324' ' ' THR . 0.6 OUTLIER -110.33 150.65 28.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 56.81 -128.42 46.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.3 m -112.04 30.13 7.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 281' ' ' LEU . 9.8 mt-30 -62.75 171.83 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.895 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.423 HG22 ' ND2' ' A' ' 320' ' ' ASN . 1.1 p -149.83 177.04 10.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.491 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.52 ' CG1' ' HD2' ' A' ' 302' ' ' ARG . 10.1 mm -103.59 131.19 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.281 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.515 ' HG3' ' CG ' ' A' ' 318' ' ' MET . 0.1 OUTLIER -103.41 -38.75 7.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.467 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 315' ' ' VAL . . . -154.63 164.81 38.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 14.6 m -158.13 164.01 37.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.501 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 31.2 p90 -166.74 165.47 16.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 291' ' ' TRP . 1.4 m-20 71.7 3.39 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -175.74 148.29 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.154 -0.966 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.462 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 38.7 m-80 -84.29 101.87 12.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.518 ' CG2' HG21 ' A' ' 304' ' ' VAL . 25.7 t -104.37 133.62 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.578 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 302' ' ' ARG . 5.1 p . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 302' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 121.337 0.589 . . . . 0.0 109.572 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . 0.52 ' HD2' ' CG1' ' A' ' 287' ' ' ILE . 45.5 mtt85 -156.09 168.93 25.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 22.9 m -121.59 121.3 37.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.518 HG21 ' CG2' ' A' ' 295' ' ' VAL . 70.8 t -106.68 142.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.521 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -129.71 160.33 65.3 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.421 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.5 Cg_endo -78.21 131.22 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.61 2.207 . . . . 0.0 110.347 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.01 -25.65 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.08 -42.27 1.06 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.35 11.48 2.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.495 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -110.24 65.33 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 70.3 m-20 -54.94 -24.21 22.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -1.174 . . . . 0.0 109.49 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 267' ' ' TYR . 87.6 m -106.56 124.08 49.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.653 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 7.4 p90 -109.92 172.22 6.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.556 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -151.62 129.51 2.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 289' ' ' ALA . 7.1 m -135.84 157.04 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -1.123 . . . . 0.0 109.656 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 14.6 m -89.74 107.24 18.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.33 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.565 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 22.2 t -79.58 106.7 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.701 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.515 ' CG ' ' HG3' ' A' ' 288' ' ' GLN . 0.2 OUTLIER -59.56 108.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.12 -0.988 . . . . 0.0 108.787 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . 0.527 ' HG2' ' CA ' ' A' ' 323' ' ' SER . 4.6 mttm -43.63 -51.31 7.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.423 ' ND2' HG22 ' A' ' 286' ' ' THR . 12.3 m-20 45.98 47.02 12.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 78.56 24.08 63.59 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.6 OUTLIER -161.16 102.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -1.118 . . . . 0.0 109.473 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.527 ' CA ' ' HG2' ' A' ' 319' ' ' LYS . 80.0 p -98.11 27.91 4.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.965 . . . . 0.0 109.707 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' THR . . . . . 0.523 HG21 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.5 141.93 28.25 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.162 -0.962 . . . . 0.0 109.109 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.558 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 20.1 m -64.46 144.77 98.6 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.005 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 24.8 Cg_endo -73.73 173.32 14.14 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.328 2.019 . . . . 0.0 110.882 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.85 148.67 24.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.632 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -141.0 132.64 27.17 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.106 -0.996 . . . . 0.0 109.819 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -126.87 155.77 42.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.393 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . 0.477 ' HB2' HG11 ' A' ' 251' ' ' VAL . 49.3 t -122.91 149.91 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.319 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.454 ' SG ' HG12 ' A' ' 269' ' ' VAL . 10.3 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.329 0.585 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.48 82.48 1.67 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.314 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 277' ' ' VAL . 6.6 p -79.76 146.04 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.721 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.519 ' N ' HG21 ' A' ' 251' ' ' VAL . 0.0 OUTLIER -129.94 171.07 13.15 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.644 ' CB ' ' CE1' ' A' ' 267' ' ' TYR . . . -126.47 161.08 28.75 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 54.2 m -164.68 112.17 1.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.264 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.453 ' HD2' ' OG1' ' A' ' 325' ' ' THR . 5.9 mtp-105 -60.57 120.46 10.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.562 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 264' ' ' ASN . . . -100.63 -92.94 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.62 164.89 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 109.595 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.5 OUTLIER -170.46 153.12 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . 0.486 ' O ' ' NZ ' ' A' ' 319' ' ' LYS . 11.7 p90 -161.21 -169.27 2.27 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 17.0 m -84.13 44.56 1.02 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.102 -0.999 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . 0.427 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.2 t70 -159.57 -35.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.541 ' HA3' ' CG ' ' A' ' 319' ' ' LYS . . . -170.28 178.82 42.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.613 ' CZ ' ' CG1' ' A' ' 317' ' ' VAL . 12.6 p90 -144.27 133.02 22.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.144 -1.21 . . . . 0.0 109.924 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 256' ' ' ALA . 91.1 m-20 -79.53 103.49 9.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.633 ' CG1' ' CE2' ' A' ' 267' ' ' TYR . 2.3 t -81.74 147.46 6.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 108.972 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.539 ' N ' HG11 ' A' ' 265' ' ' VAL . 18.7 p -126.87 95.4 4.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.323 -0.861 . . . . 0.0 109.174 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.644 ' CE1' ' CB ' ' A' ' 253' ' ' ALA . 43.6 m-85 -82.33 129.82 34.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.482 ' CA ' HG22 ' A' ' 312' ' ' THR . 0.7 OUTLIER -108.98 116.2 31.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.084 -1.01 . . . . 0.0 110.032 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.581 HG23 ' CZ3' ' A' ' 275' ' ' TRP . 89.5 t -88.19 142.53 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.464 ' N ' HG11 ' A' ' 269' ' ' VAL . 2.7 t -154.76 126.65 7.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.453 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.16 -38.49 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.46 166.09 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -1.099 . . . . 0.0 109.456 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.05 -41.28 7.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.179 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.86 70.91 10.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 108.951 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.581 ' CZ3' HG23 ' A' ' 269' ' ' VAL . 57.7 p-90 -115.57 173.19 6.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 46.2 m -142.6 105.55 4.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.399 -0.813 . . . . 0.0 109.102 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.575 HG21 ' CE3' ' A' ' 275' ' ' TRP . 42.3 t -86.25 96.22 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.339 -0.85 . . . . 0.0 109.813 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.23 105.72 1.81 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 108.821 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 304' ' ' VAL . 12.6 mt -80.03 143.36 34.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -135.44 92.67 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.293 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -60.01 163.62 4.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.526 ' ND2' HG21 ' A' ' 324' ' ' THR . 0.7 OUTLIER -111.02 153.97 24.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.417 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.78 -147.57 14.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 285' ' ' GLN . 6.2 m -89.53 19.6 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -1.14 . . . . 0.0 109.467 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.472 ' OE1' HG12 ' A' ' 317' ' ' VAL . 67.7 mt-30 -46.99 173.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.308 -0.87 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.464 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.95 163.21 40.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.7 mm -102.18 108.29 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.827 . . . . 0.0 109.145 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.478 ' CB ' ' HE3' ' A' ' 318' ' ' MET . 7.8 tm0? -83.06 -34.76 26.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.969 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -152.81 171.8 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.193 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 15.2 m -167.82 165.1 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.519 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 29.4 p90 -168.67 170.37 9.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 109.909 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.518 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 1.8 m-20 69.95 4.61 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.784 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 305' ' ' THR . . . -178.07 148.37 0.5 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.183 -0.948 . . . . 0.0 109.623 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.436 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 11.8 m-80 -86.44 100.59 12.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.897 . . . . 0.0 109.308 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.486 ' CG2' HG21 ' A' ' 304' ' ' VAL . 3.0 p -114.88 139.71 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.425 ' C ' ' HB3' ' A' ' 302' ' ' ARG . 1.1 p . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 109.516 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 121.28 0.562 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . 0.425 ' HB3' ' C ' ' A' ' 296' ' ' THR . 10.9 mtt180 -139.37 134.22 32.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 48.8 m -80.37 123.89 28.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.559 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 279' ' ' LEU . 79.5 t -99.3 142.69 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.9 OUTLIER -128.83 162.98 48.41 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.01 133.28 12.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.597 2.198 . . . . 0.0 110.368 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -80.02 -32.47 39.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 148.49 -33.57 1.19 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.8 t -150.72 18.55 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -1.143 . . . . 0.0 109.458 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -120.81 65.17 0.46 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.462 ' O ' HG22 ' A' ' 269' ' ' VAL . 1.1 m-80 -51.08 -28.67 11.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -1.157 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.482 HG22 ' CA ' ' A' ' 268' ' ' SER . 66.3 m -101.08 123.92 45.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' A' ' 267' ' ' TYR . 6.3 p90 -109.82 170.91 7.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -149.15 127.67 2.55 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 289' ' ' ALA . 5.9 m -134.13 152.15 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 109.828 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.515 HG23 ' CE ' ' A' ' 318' ' ' MET . 18.9 m -82.22 134.39 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.057 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.613 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 85.6 t -107.88 124.95 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.515 ' CE ' HG23 ' A' ' 316' ' ' THR . 0.0 OUTLIER -83.19 95.68 8.2 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.106 -0.996 . . . . 0.0 108.523 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . 0.541 ' CG ' ' HA3' ' A' ' 262' ' ' GLY . 11.9 mttt -42.59 -47.13 5.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.458 -0.776 . . . . 0.0 109.836 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 319' ' ' LYS . 93.2 m-20 42.76 43.92 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 92.32 20.65 34.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 13.9 m -160.15 99.99 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -1.182 . . . . 0.0 109.58 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.522 ' CB ' ' HD3' ' A' ' 319' ' ' LYS . 61.5 p -93.29 29.8 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' THR . . . . . 0.526 HG21 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.89 143.49 26.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.146 -0.971 . . . . 0.0 109.482 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.594 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 16.2 m -68.47 146.52 97.83 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.594 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 25.3 Cg_endo -73.25 172.6 15.25 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.249 1.966 . . . . 0.0 110.88 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.53 148.69 24.51 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' A' ' 267' ' ' TYR . . . -140.46 132.39 27.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 109.623 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -127.63 155.85 43.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 109.722 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . 0.495 ' HB2' HG13 ' A' ' 251' ' ' VAL . 43.9 t -124.22 152.87 42.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.588 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 5.5 p . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.362 0.601 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.1 t -108.13 82.41 1.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 277' ' ' VAL . 6.2 p -79.85 146.34 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.518 ' N ' HG21 ' A' ' 251' ' ' VAL . 0.0 OUTLIER -130.84 168.14 17.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.645 ' CB ' ' CE1' ' A' ' 267' ' ' TYR . . . -129.01 162.97 26.38 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -169.02 115.12 0.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.441 ' CG ' ' OG1' ' A' ' 325' ' ' THR . 6.4 mtm-85 -59.68 119.88 8.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.457 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -101.86 -89.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 1.7 mm-40 -84.06 165.38 18.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -170.41 149.3 3.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.373 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . 0.472 ' O ' ' HE3' ' A' ' 319' ' ' LYS . 13.4 p90 -158.84 -168.32 2.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.419 -0.801 . . . . 0.0 109.038 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t -86.5 47.11 1.43 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.199 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . 0.435 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.5 t70 -160.23 -37.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 109.957 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.514 ' HA3' ' CG ' ' A' ' 319' ' ' LYS . . . -172.27 171.1 44.03 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.636 ' CZ ' ' CG1' ' A' ' 317' ' ' VAL . 16.8 p90 -131.58 136.22 47.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.951 -1.323 . . . . 0.0 110.061 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 38.8 t30 -79.34 111.4 15.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.584 HG12 ' CE2' ' A' ' 267' ' ' TYR . 2.8 t -92.27 147.08 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.477 -0.764 . . . . 0.0 109.328 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.528 ' N ' HG11 ' A' ' 265' ' ' VAL . 14.0 p -128.78 94.28 3.81 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.4 -0.812 . . . . 0.0 109.166 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.674 ' CD2' ' CZ ' ' A' ' 313' ' ' PHE . 37.1 m-85 -81.99 126.73 32.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 312' ' ' THR . 2.6 t -105.7 115.96 31.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.923 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.578 HG23 ' CH2' ' A' ' 275' ' ' TRP . 59.1 t -88.27 145.8 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.507 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.506 ' N ' HG11 ' A' ' 269' ' ' VAL . 2.6 m -157.64 126.04 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.0 109.411 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.9 -38.44 1.75 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.55 167.59 29.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -1.09 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 306' ' ' PRO . 2.0 m -99.55 -41.27 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -85.21 67.6 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 108.913 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.578 ' CH2' HG23 ' A' ' 269' ' ' VAL . 56.2 p-90 -110.16 173.41 6.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.496 -0.752 . . . . 0.0 109.688 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.41 112.9 7.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.53 ' CG2' HG22 ' A' ' 251' ' ' VAL . 42.8 t -96.49 101.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.52 106.57 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.908 . . . . 0.0 108.838 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 313' ' ' PHE . 13.6 mt -80.82 143.01 33.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.838 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -134.73 105.54 6.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.265 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' A' ' 287' ' ' ILE . 3.9 mm? -66.08 171.08 4.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.708 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.442 ' HB2' ' OE1' ' A' ' 285' ' ' GLN . 1.7 m-80 -118.55 153.96 33.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.65 -148.3 9.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 285' ' ' GLN . 19.5 p -80.35 5.65 14.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 109.63 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.463 ' C ' ' CG2' ' A' ' 286' ' ' THR . 75.2 mt-30 -43.88 166.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.65 174.06 15.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 109.529 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.492 ' CD1' HD22 ' A' ' 281' ' ' LEU . 17.8 mm -94.49 132.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.358 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 40.1 tt0 -106.83 -36.97 6.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.582 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -164.45 169.96 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.639 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 71.2 p -158.13 166.5 32.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.315 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.563 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 32.0 p90 -167.56 172.09 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 291' ' ' TRP . 33.5 m-20 63.3 10.87 4.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.424 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . -178.34 149.2 0.51 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -79.97 100.59 8.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 0.0 109.278 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.514 ' CG2' HG23 ' A' ' 304' ' ' VAL . 4.6 t -107.59 137.66 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.458 HG21 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.244 0.545 . . . . 0.0 109.673 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . 0.473 ' NE ' HG13 ' A' ' 287' ' ' ILE . 5.7 mtm180 -140.48 143.63 35.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 89.7 m -90.34 121.78 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.514 HG23 ' CG2' ' A' ' 295' ' ' VAL . 55.3 t -105.32 145.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.472 ' N ' HG11 ' A' ' 304' ' ' VAL . 0.8 OUTLIER -141.33 154.8 67.67 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.8 Cg_endo -78.12 144.46 21.06 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -93.56 -15.94 24.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.63 4.94 16.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.59 27.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -1.179 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.13 63.62 0.33 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 269' ' ' VAL . 56.5 m-20 -53.25 -31.98 46.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -1.138 . . . . 0.0 109.394 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 267' ' ' TYR . 61.4 m -97.44 123.4 41.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.674 ' CZ ' ' CD2' ' A' ' 267' ' ' TYR . 7.7 p90 -108.08 171.96 7.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.576 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.563 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -148.91 128.79 2.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 289' ' ' ALA . 13.6 m -132.45 159.18 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.9 m -92.84 110.09 21.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.636 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 46.6 t -84.19 127.23 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 1.5 mmt -79.75 103.74 9.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 108.75 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . 0.514 ' CG ' ' HA3' ' A' ' 262' ' ' GLY . 32.6 mttt -43.03 -46.91 5.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -0.832 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 318' ' ' MET . 11.4 m-20 43.47 44.46 5.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.203 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 122.87 -51.32 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' SER . . . . . 0.442 ' HB3' ' OG1' ' A' ' 324' ' ' THR . 0.4 OUTLIER -138.23 140.45 39.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -1.176 . . . . 0.0 109.896 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.568 ' O ' ' CE1' ' A' ' 263' ' ' PHE . 1.1 p -81.4 6.72 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -36.09 129.14 0.69 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.608 -0.683 . . . . 0.0 111.11 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.57 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 21.0 m -69.26 144.12 94.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 24.8 Cg_endo -72.62 171.99 16.09 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.15 1.9 . . . . 0.0 111.109 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.77 149.67 23.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.581 ' HB1' ' CE1' ' A' ' 267' ' ' TYR . . . -139.58 131.97 28.48 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.975 -1.078 . . . . 0.0 109.965 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -124.36 156.1 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.53 -0.731 . . . . 0.0 109.369 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . 0.493 ' HB2' HG13 ' A' ' 251' ' ' VAL . 48.9 t -123.97 135.44 53.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.883 . . . . 0.0 109.76 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.314 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 330' ' ' CYS . 11.2 p . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.271 0.558 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.15 81.72 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.534 ' CB ' HG23 ' A' ' 277' ' ' VAL . 6.2 p -79.27 145.82 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.505 ' N ' HG21 ' A' ' 251' ' ' VAL . 0.0 OUTLIER -134.71 170.6 15.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -118.45 164.49 15.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 109.94 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 18.2 m -167.08 104.46 0.55 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.309 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -57.65 125.17 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.704 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -103.58 -83.08 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.709 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 257' ' ' GLU . 39.0 mm-40 -97.53 168.62 10.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 0.0 109.652 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -170.41 146.62 2.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . 0.425 ' CE2' ' O ' ' A' ' 262' ' ' GLY . 12.4 p90 -155.85 -168.46 2.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 43.0 m -84.19 45.65 1.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 110.065 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . 0.481 ' OD1' ' CE ' ' A' ' 318' ' ' MET . 2.1 t0 -159.99 -36.84 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 319' ' ' LYS . . . -174.64 170.65 43.8 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.588 ' CE1' ' HB ' ' A' ' 317' ' ' VAL . 5.6 p90 -135.43 138.0 42.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.267 . . . . 0.0 109.919 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 90.5 m-20 -79.68 99.04 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.64 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.601 ' CG1' ' CE1' ' A' ' 267' ' ' TYR . 2.3 t -81.16 147.42 6.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 108.786 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.526 ' N ' HG11 ' A' ' 265' ' ' VAL . 23.9 p -129.39 94.51 3.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.655 ' CD1' ' CZ ' ' A' ' 313' ' ' PHE . 47.9 m-85 -80.32 130.3 35.09 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.455 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.2 t -110.2 121.62 45.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.074 -1.016 . . . . 0.0 110.189 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.532 HG13 ' CD1' ' A' ' 275' ' ' TRP . 79.5 t -99.39 131.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.34 116.64 11.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.81 -38.48 0.99 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.96 165.71 35.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -1.09 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -98.17 -43.08 7.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.171 -0.955 . . . . 0.0 109.212 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -81.12 75.6 8.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.875 . . . . 0.0 108.94 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.532 ' CD1' HG13 ' A' ' 269' ' ' VAL . 48.1 p-90 -119.19 173.65 6.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.85 . . . . 0.0 109.648 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.3 m -140.64 115.08 9.38 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.408 -0.807 . . . . 0.0 108.888 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 251' ' ' VAL . 77.1 t -104.72 105.88 19.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 9.6 t30 -78.93 119.76 22.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.611 ' CD1' ' CZ ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -101.25 128.94 47.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.139 -0.976 . . . . 0.0 110.303 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -116.87 97.2 5.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 109.01 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 326' ' ' PRO . 1.1 mp -60.77 171.94 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 110.098 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.528 ' ND2' HG21 ' A' ' 324' ' ' THR . 0.3 OUTLIER -111.52 164.64 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.604 -179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 48.14 -153.42 1.88 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.4 p -88.04 17.17 5.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.514 ' OE1' ' CG1' ' A' ' 317' ' ' VAL . 8.3 mt-30 -45.33 171.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 285' ' ' GLN . 1.1 p -152.65 170.39 20.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.844 . . . . 0.0 109.572 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.48 ' CG1' ' HD3' ' A' ' 302' ' ' ARG . 19.3 mm -92.82 121.32 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.451 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 7.6 tp-100 -95.94 -35.62 11.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -163.11 166.52 23.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.612 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.408 ' CB ' HG11 ' A' ' 315' ' ' VAL . 96.6 p -156.65 168.44 27.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.382 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 24.6 p90 -169.78 170.31 7.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.699 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 52.0 m-20 61.9 12.19 4.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . -178.67 173.82 1.25 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.451 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 15.6 m-80 -107.57 101.25 10.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.33 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.515 ' CG2' HG21 ' A' ' 304' ' ' VAL . 46.1 t -106.36 126.28 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 295' ' ' VAL . 3.5 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 302' ' ' ARG . 67.1 p . . . . . 0 N--CA 1.483 1.206 0 CA-C-O 121.189 0.519 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . 0.48 ' HD3' ' CG1' ' A' ' 287' ' ' ILE . 0.6 OUTLIER -154.54 167.51 29.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 97.9 m -117.45 124.65 49.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.374 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.515 HG21 ' CG2' ' A' ' 295' ' ' VAL . 74.5 t -106.53 139.26 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -124.1 162.69 40.14 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.389 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -78.37 135.04 13.07 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.609 2.206 . . . . 0.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.62 -29.04 26.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.03 5.72 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.8 t -153.26 24.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.156 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -139.79 64.99 0.53 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.25 -25.41 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -1.168 . . . . 0.0 109.453 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 267' ' ' TYR . 94.7 m -106.56 127.15 53.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.655 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 8.8 p90 -112.1 172.47 6.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 265' ' ' VAL . . . -153.66 132.19 3.51 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 289' ' ' ALA . 5.4 m -140.18 152.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -1.17 . . . . 0.0 109.796 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 13.5 m -81.61 128.19 33.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 263' ' ' PHE . 58.8 t -100.37 106.07 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.793 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.481 ' CE ' ' OD1' ' A' ' 261' ' ' ASP . 2.0 mmt -60.42 97.57 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.033 -1.042 . . . . 0.0 108.682 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . 0.512 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 30.4 mttt -42.33 -46.32 4.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.699 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 319' ' ' LYS . 28.8 m-20 43.88 46.22 6.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.254 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.35 24.41 51.26 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 285' ' ' GLN . 16.7 t -160.65 97.94 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -1.105 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.512 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 21.2 p -92.95 31.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' THR . . . . . 0.528 HG21 ' ND2' ' A' ' 282' ' ' ASN . 0.8 OUTLIER -90.64 146.37 24.09 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.129 -0.982 . . . . 0.0 109.134 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.568 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 18.2 m -69.05 145.61 96.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 108.988 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 24.4 Cg_endo -72.56 172.6 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.237 1.958 . . . . 0.0 110.66 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -96.62 159.96 14.65 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -156.67 132.4 9.53 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.843 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -133.18 154.84 50.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.402 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . 0.506 ' HB2' ' CG1' ' A' ' 251' ' ' VAL . 44.4 t -110.78 148.26 32.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.86 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.463 -179.903 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -171.51 99.36 0.14 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 2.6 p -59.87 147.55 38.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -1.144 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 34.4 m -121.94 84.3 2.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.271 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.526 HG22 ' CG2' ' A' ' 277' ' ' VAL . 3.5 p -79.96 149.2 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 268' ' ' SER . 0.0 OUTLIER -131.48 164.1 26.5 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.63 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -120.01 162.74 18.72 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.399 -0.813 . . . . 0.0 109.899 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.503 HG23 ' N ' ' A' ' 255' ' ' ARG . 15.8 m -169.64 161.69 9.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.252 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.503 ' N ' HG23 ' A' ' 254' ' ' THR . 0.6 OUTLIER -106.69 119.71 40.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.506 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 264' ' ' ASN . . . -97.68 -89.84 0.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.829 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 264' ' ' ASN . 2.8 mt-10 -91.75 168.63 11.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.764 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 9.0 tt0 -170.29 148.85 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -157.27 -168.93 2.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.478 -0.764 . . . . 0.0 108.957 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t -84.71 46.05 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.113 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -160.22 -36.33 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.493 ' HA3' ' HG3' ' A' ' 319' ' ' LYS . . . -172.63 171.6 44.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.567 ' CE1' ' HB ' ' A' ' 317' ' ' VAL . 5.9 p90 -134.66 137.2 43.4 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.047 -1.267 . . . . 0.0 109.84 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.479 ' O ' ' HB1' ' A' ' 256' ' ' ALA . 77.5 m-20 -79.09 102.16 8.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.583 HG12 ' CE1' ' A' ' 267' ' ' TYR . 4.3 t -78.19 150.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.311 -0.868 . . . . 0.0 108.982 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.539 ' N ' HG11 ' A' ' 265' ' ' VAL . 15.2 p -133.5 93.43 3.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.662 ' CD1' ' CZ ' ' A' ' 313' ' ' PHE . 48.8 m-85 -81.32 132.4 35.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 252' ' ' THR . 6.5 m -111.06 119.63 39.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.015 -1.053 . . . . 0.0 110.319 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.488 HG13 ' CD1' ' A' ' 275' ' ' TRP . 71.7 t -97.93 138.01 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.399 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.458 ' N ' HG11 ' A' ' 269' ' ' VAL . 14.8 m -149.49 130.38 14.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 132.1 -37.31 2.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.2 m -150.89 159.85 44.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -97.17 -44.57 6.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 108.995 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -80.22 77.41 6.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 108.834 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.488 ' CD1' HG13 ' A' ' 269' ' ' VAL . 60.0 p-90 -123.75 165.39 17.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 109.544 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 330' ' ' CYS . 86.5 m -135.98 118.19 15.55 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.144 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.526 ' CG2' HG22 ' A' ' 251' ' ' VAL . 44.8 t -105.16 104.48 17.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.67 109.36 8.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 108.96 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.431 HD13 ' CE1' ' A' ' 313' ' ' PHE . 11.8 mt -79.93 145.97 32.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.65 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.7 96.14 3.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 287' ' ' ILE . 3.9 mm? -59.89 169.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.51 ' ND2' HG21 ' A' ' 324' ' ' THR . 0.7 OUTLIER -115.57 148.54 39.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.26 -143.61 40.93 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.5 p -84.13 7.94 17.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.598 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.481 ' C ' ' CG2' ' A' ' 286' ' ' THR . 61.8 mt-30 -44.26 167.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -155.89 174.89 14.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.541 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.518 ' CD1' HD22 ' A' ' 281' ' ' LEU . 13.9 mm -98.59 109.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.465 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 0.3 OUTLIER -85.56 -34.23 21.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -165.45 171.36 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 109.831 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.531 ' CB ' ' CG1' ' A' ' 315' ' ' VAL . 43.5 p -161.86 169.98 20.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.347 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 32.1 p90 -169.99 165.91 9.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.3 m-20 71.79 3.42 4.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 109.68 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . -174.42 145.66 0.99 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.49 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.65 101.25 12.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.423 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.519 ' CG2' HG21 ' A' ' 304' ' ' VAL . 3.4 p -116.96 141.84 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.15 170.8 20.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.583 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . 0.524 ' CA ' ' HD3' ' A' ' 302' ' ' ARG . . . 168.22 -163.92 37.57 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.48 49.39 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.227 -1.161 . . . . 0.0 109.508 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -167.1 -114.64 0.3 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.509 ' O ' ' CG2' ' A' ' 301' ' ' THR . 2.7 m -117.8 20.66 13.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -1.16 . . . . 0.0 109.417 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 300' ' ' SER . 19.4 p -160.61 156.11 25.14 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.524 ' HD3' ' CA ' ' A' ' 297' ' ' GLY . 4.2 mmt180 -139.03 132.24 29.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 295' ' ' VAL . 41.3 m -76.29 118.63 19.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.952 . . . . 0.0 109.503 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.519 HG21 ' CG2' ' A' ' 295' ' ' VAL . 75.6 t -101.59 149.35 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.2 p -146.15 148.36 34.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.336 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.438 ' HB3' ' CE2' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -77.91 138.64 16.79 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.588 2.192 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.98 -17.91 51.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.13 -37.15 1.43 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.21 11.06 3.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.129 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -109.93 65.14 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 7.1 m120 -58.63 -28.32 65.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -1.163 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 267' ' ' TYR . 88.6 m -102.01 125.58 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.662 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 7.0 p90 -111.47 171.46 7.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 265' ' ' VAL . . . -151.34 128.68 2.64 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 290' ' ' SER . 17.9 m -133.83 158.19 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.58 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.2 m -88.87 109.22 20.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 263' ' ' PHE . 25.2 t -79.5 106.6 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 1.1 mmt -59.31 94.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.125 -0.985 . . . . 0.0 108.75 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.528 ' HD3' ' CB ' ' A' ' 323' ' ' SER . 21.2 mttt -41.07 -45.29 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.718 . . . . 0.0 109.775 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 319' ' ' LYS . 55.0 m-20 41.06 45.4 2.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.511 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.61 29.96 28.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 319' ' ' LYS . 29.0 t -160.05 110.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -1.15 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.528 ' CB ' ' HD3' ' A' ' 319' ' ' LYS . 11.5 p -98.93 25.44 6.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.69 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.51 HG21 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.92 145.72 24.5 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.113 -0.992 . . . . 0.0 109.572 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.595 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 16.3 m -71.14 146.47 92.52 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.595 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 24.9 Cg_endo -73.42 173.37 13.92 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.169 1.913 . . . . 0.0 110.761 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.65 149.25 24.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.58 ' HB1' ' CE2' ' A' ' 267' ' ' TYR . . . -142.43 132.89 25.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.079 -1.013 . . . . 0.0 109.864 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -128.74 156.63 43.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.494 -0.753 . . . . 0.0 109.29 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.478 ' HB2' HG13 ' A' ' 251' ' ' VAL . 22.8 t -131.87 162.84 29.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.96 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -149.69 149.89 31.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.13 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -81.57 111.13 3.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.336 -1.097 . . . . 0.0 109.498 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.428 ' C ' ' HA ' ' A' ' 331' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -162.9 -129.71 1.05 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 9.6 p -60.3 171.74 0.98 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.247 -1.149 . . . . 0.0 109.544 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.82 81.16 1.62 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.525 HG23 ' CG2' ' A' ' 277' ' ' VAL . 7.3 p -79.58 149.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.88 171.39 14.47 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -127.99 164.91 21.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -168.55 107.06 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.436 ' HG2' ' OG1' ' A' ' 325' ' ' THR . 1.3 mmm180 -48.97 123.39 7.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 264' ' ' ASN . . . -105.41 -90.38 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.706 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 4.3 mm-40 -88.03 165.62 15.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 109.549 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 84.6 tt0 -170.35 155.82 5.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.439 ' O ' ' HE3' ' A' ' 319' ' ' LYS . 11.7 p90 -163.01 -168.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 t -84.34 43.33 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.2 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 319' ' ' LYS . 3.1 t70 -155.68 -38.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.783 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.457 ' O ' ' HE3' ' A' ' 319' ' ' LYS . . . -167.92 -169.08 30.96 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 31.9 p90 -152.21 128.67 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -1.235 . . . . 0.0 109.894 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.488 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 10.0 t30 -79.59 113.18 17.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.82 . . . . 0.0 109.608 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.619 ' CG1' ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -92.09 148.16 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 0.0 109.111 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.531 ' N ' HG11 ' A' ' 265' ' ' VAL . 23.1 p -126.77 95.36 4.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.354 -0.841 . . . . 0.0 109.246 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.653 ' CD1' ' CZ ' ' A' ' 313' ' ' PHE . 42.4 m-85 -80.99 130.84 35.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 108.765 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.453 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.3 p -109.17 119.55 39.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.082 -1.012 . . . . 0.0 110.022 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.585 HG12 ' CD1' ' A' ' 275' ' ' TRP . 79.2 t -92.85 135.62 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.52 116.08 7.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 149.12 -39.17 0.94 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.12 168.58 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -1.118 . . . . 0.0 109.42 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -42.13 7.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.891 . . . . 0.0 109.23 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.64 71.41 10.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 108.868 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.585 ' CD1' HG12 ' A' ' 269' ' ' VAL . 56.7 p-90 -115.81 172.4 7.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 0.0 109.656 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 83.6 m -141.36 108.54 5.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.313 -0.867 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.578 HG21 ' CE3' ' A' ' 275' ' ' TRP . 46.7 t -91.63 103.29 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.354 -0.841 . . . . 0.0 109.906 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.17 111.23 8.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 108.904 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.513 ' CD2' HG13 ' A' ' 277' ' ' VAL . 3.9 mm? -80.09 145.93 32.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.845 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.81 92.53 2.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.221 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.518 ' CD1' HG12 ' A' ' 317' ' ' VAL . 3.9 mm? -59.93 165.62 3.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.567 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.523 ' ND2' HG21 ' A' ' 324' ' ' THR . 0.6 OUTLIER -110.33 150.65 28.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 56.81 -128.42 46.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.3 m -112.04 30.13 7.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 281' ' ' LEU . 9.8 mt-30 -62.75 171.83 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.895 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.423 HG22 ' ND2' ' A' ' 320' ' ' ASN . 1.1 p -149.83 177.04 10.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.491 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.52 ' CG1' ' HD2' ' A' ' 302' ' ' ARG . 10.1 mm -103.59 131.19 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.281 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.515 ' HG3' ' CG ' ' A' ' 318' ' ' MET . 0.1 OUTLIER -103.41 -38.75 7.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.467 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 315' ' ' VAL . . . -154.63 164.81 38.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 14.6 m -158.13 164.01 37.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.501 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 31.2 p90 -166.74 165.47 16.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 291' ' ' TRP . 1.4 m-20 71.7 3.39 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -175.74 148.29 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.154 -0.966 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.462 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 38.7 m-80 -84.29 101.87 12.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.518 ' CG2' HG21 ' A' ' 304' ' ' VAL . 25.7 t -104.37 133.62 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.578 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 302' ' ' ARG . 5.1 p -112.9 153.83 27.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . 0.456 ' HA3' ' NE ' ' A' ' 302' ' ' ARG . . . -93.48 163.43 26.22 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.54 58.59 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.301 -1.117 . . . . 0.0 109.419 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.42 -91.21 1.45 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.63 -48.92 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -1.134 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 302' ' ' ARG . 0.8 OUTLIER -79.53 172.77 13.34 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.52 ' HD2' ' CG1' ' A' ' 287' ' ' ILE . 45.5 mtt85 -156.09 168.93 25.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 22.9 m -121.59 121.3 37.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.518 HG21 ' CG2' ' A' ' 295' ' ' VAL . 70.8 t -106.68 142.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.521 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -129.71 160.33 65.3 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.421 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.5 Cg_endo -78.21 131.22 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.61 2.207 . . . . 0.0 110.347 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.01 -25.65 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.08 -42.27 1.06 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.35 11.48 2.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.495 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -110.24 65.33 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 70.3 m-20 -54.94 -24.21 22.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -1.174 . . . . 0.0 109.49 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 267' ' ' TYR . 87.6 m -106.56 124.08 49.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.653 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 7.4 p90 -109.92 172.22 6.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.556 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -151.62 129.51 2.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 289' ' ' ALA . 7.1 m -135.84 157.04 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -1.123 . . . . 0.0 109.656 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 14.6 m -89.74 107.24 18.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.33 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.565 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 22.2 t -79.58 106.7 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.701 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.515 ' CG ' ' HG3' ' A' ' 288' ' ' GLN . 0.2 OUTLIER -59.56 108.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.12 -0.988 . . . . 0.0 108.787 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.527 ' HG2' ' CA ' ' A' ' 323' ' ' SER . 4.6 mttm -43.63 -51.31 7.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.423 ' ND2' HG22 ' A' ' 286' ' ' THR . 12.3 m-20 45.98 47.02 12.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 78.56 24.08 63.59 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.6 OUTLIER -161.16 102.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -1.118 . . . . 0.0 109.473 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.527 ' CA ' ' HG2' ' A' ' 319' ' ' LYS . 80.0 p -98.11 27.91 4.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.965 . . . . 0.0 109.707 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.523 HG21 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.5 141.93 28.25 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.162 -0.962 . . . . 0.0 109.109 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.558 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 20.1 m -64.46 144.77 98.6 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.005 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 24.8 Cg_endo -73.73 173.32 14.14 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.328 2.019 . . . . 0.0 110.882 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.85 148.67 24.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.632 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -141.0 132.64 27.17 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.106 -0.996 . . . . 0.0 109.819 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -126.87 155.77 42.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.393 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.477 ' HB2' HG11 ' A' ' 251' ' ' VAL . 49.3 t -122.91 149.91 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . 0.428 ' HA ' ' C ' ' A' ' 247' ' ' THR . . . -149.03 165.7 30.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.319 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -76.37 115.89 4.56 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.26 -1.141 . . . . 0.0 109.497 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.34 140.39 7.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.454 ' SG ' HG12 ' A' ' 269' ' ' VAL . 10.3 p -59.69 171.32 0.9 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -1.153 . . . . 0.0 109.593 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.48 82.48 1.67 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.314 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 277' ' ' VAL . 6.6 p -79.76 146.04 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.721 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.519 ' N ' HG21 ' A' ' 251' ' ' VAL . 0.0 OUTLIER -129.94 171.07 13.15 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.644 ' CB ' ' CE1' ' A' ' 267' ' ' TYR . . . -126.47 161.08 28.75 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 54.2 m -164.68 112.17 1.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.264 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.453 ' HD2' ' OG1' ' A' ' 325' ' ' THR . 5.9 mtp-105 -60.57 120.46 10.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.562 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 264' ' ' ASN . . . -100.63 -92.94 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.62 164.89 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 109.595 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.5 OUTLIER -170.46 153.12 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.486 ' O ' ' NZ ' ' A' ' 319' ' ' LYS . 11.7 p90 -161.21 -169.27 2.27 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 17.0 m -84.13 44.56 1.02 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.102 -0.999 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . 0.427 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.2 t70 -159.57 -35.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.541 ' HA3' ' CG ' ' A' ' 319' ' ' LYS . . . -170.28 178.82 42.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.613 ' CZ ' ' CG1' ' A' ' 317' ' ' VAL . 12.6 p90 -144.27 133.02 22.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.144 -1.21 . . . . 0.0 109.924 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 256' ' ' ALA . 91.1 m-20 -79.53 103.49 9.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.633 ' CG1' ' CE2' ' A' ' 267' ' ' TYR . 2.3 t -81.74 147.46 6.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 108.972 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.539 ' N ' HG11 ' A' ' 265' ' ' VAL . 18.7 p -126.87 95.4 4.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.323 -0.861 . . . . 0.0 109.174 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.644 ' CE1' ' CB ' ' A' ' 253' ' ' ALA . 43.6 m-85 -82.33 129.82 34.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.482 ' CA ' HG22 ' A' ' 312' ' ' THR . 0.7 OUTLIER -108.98 116.2 31.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.084 -1.01 . . . . 0.0 110.032 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.581 HG23 ' CZ3' ' A' ' 275' ' ' TRP . 89.5 t -88.19 142.53 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.464 ' N ' HG11 ' A' ' 269' ' ' VAL . 2.7 t -154.76 126.65 7.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.453 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.16 -38.49 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.46 166.09 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -1.099 . . . . 0.0 109.456 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.05 -41.28 7.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.179 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.86 70.91 10.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 108.951 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.581 ' CZ3' HG23 ' A' ' 269' ' ' VAL . 57.7 p-90 -115.57 173.19 6.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 46.2 m -142.6 105.55 4.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.399 -0.813 . . . . 0.0 109.102 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.575 HG21 ' CE3' ' A' ' 275' ' ' TRP . 42.3 t -86.25 96.22 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.339 -0.85 . . . . 0.0 109.813 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.23 105.72 1.81 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 108.821 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 304' ' ' VAL . 12.6 mt -80.03 143.36 34.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -135.44 92.67 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.293 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -60.01 163.62 4.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.526 ' ND2' HG21 ' A' ' 324' ' ' THR . 0.7 OUTLIER -111.02 153.97 24.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.417 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.78 -147.57 14.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 285' ' ' GLN . 6.2 m -89.53 19.6 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -1.14 . . . . 0.0 109.467 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.472 ' OE1' HG12 ' A' ' 317' ' ' VAL . 67.7 mt-30 -46.99 173.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.308 -0.87 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.464 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.95 163.21 40.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 17.7 mm -102.18 108.29 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.827 . . . . 0.0 109.145 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.478 ' CB ' ' HE3' ' A' ' 318' ' ' MET . 7.8 tm0? -83.06 -34.76 26.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.969 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -152.81 171.8 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.193 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 15.2 m -167.82 165.1 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.519 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 29.4 p90 -168.67 170.37 9.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 109.909 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.518 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 1.8 m-20 69.95 4.61 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.784 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 305' ' ' THR . . . -178.07 148.37 0.5 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.183 -0.948 . . . . 0.0 109.623 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.436 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 11.8 m-80 -86.44 100.59 12.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.897 . . . . 0.0 109.308 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.486 ' CG2' HG21 ' A' ' 304' ' ' VAL . 3.0 p -114.88 139.71 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.425 ' C ' ' HB3' ' A' ' 302' ' ' ARG . 1.1 p -160.0 156.03 26.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 109.516 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . 0.51 ' N ' ' HD3' ' A' ' 302' ' ' ARG . . . 176.83 -177.56 48.14 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.7 m -170.39 48.23 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.221 -1.164 . . . . 0.0 109.445 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 300' ' ' SER . . . -164.87 38.99 0.29 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 299' ' ' GLY . 0.1 OUTLIER 76.35 13.62 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -1.133 . . . . 0.0 109.493 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 300' ' ' SER . 13.4 p -160.51 143.71 13.43 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.248 -0.908 . . . . 0.0 109.552 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' A' ' 297' ' ' GLY . 10.9 mtt180 -139.37 134.22 32.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 48.8 m -80.37 123.89 28.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.559 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 279' ' ' LEU . 79.5 t -99.3 142.69 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.9 OUTLIER -128.83 162.98 48.41 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.01 133.28 12.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.597 2.198 . . . . 0.0 110.368 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -80.02 -32.47 39.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 148.49 -33.57 1.19 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.8 t -150.72 18.55 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -1.143 . . . . 0.0 109.458 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -120.81 65.17 0.46 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.462 ' O ' HG22 ' A' ' 269' ' ' VAL . 1.1 m-80 -51.08 -28.67 11.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -1.157 . . . . 0.0 109.478 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.482 HG22 ' CA ' ' A' ' 268' ' ' SER . 66.3 m -101.08 123.92 45.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' A' ' 267' ' ' TYR . 6.3 p90 -109.82 170.91 7.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -149.15 127.67 2.55 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 289' ' ' ALA . 5.9 m -134.13 152.15 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 109.828 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.515 HG23 ' CE ' ' A' ' 318' ' ' MET . 18.9 m -82.22 134.39 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.057 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.613 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 85.6 t -107.88 124.95 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.515 ' CE ' HG23 ' A' ' 316' ' ' THR . 0.0 OUTLIER -83.19 95.68 8.2 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.106 -0.996 . . . . 0.0 108.523 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.541 ' CG ' ' HA3' ' A' ' 262' ' ' GLY . 11.9 mttt -42.59 -47.13 5.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.458 -0.776 . . . . 0.0 109.836 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 319' ' ' LYS . 93.2 m-20 42.76 43.92 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 92.32 20.65 34.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 13.9 m -160.15 99.99 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -1.182 . . . . 0.0 109.58 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.522 ' CB ' ' HD3' ' A' ' 319' ' ' LYS . 61.5 p -93.29 29.8 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.526 HG21 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.89 143.49 26.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.146 -0.971 . . . . 0.0 109.482 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.594 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 16.2 m -68.47 146.52 97.83 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.594 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 25.3 Cg_endo -73.25 172.6 15.25 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.249 1.966 . . . . 0.0 110.88 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.53 148.69 24.51 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' A' ' 267' ' ' TYR . . . -140.46 132.39 27.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 109.623 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -127.63 155.85 43.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 109.722 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.495 ' HB2' HG13 ' A' ' 251' ' ' VAL . 43.9 t -124.22 152.87 42.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.588 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -156.9 164.77 37.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 113.65 -109.38 2.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.277 -1.131 . . . . 0.0 109.526 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 331' ' ' ALA . 1.9 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 107.76 -85.77 0.43 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 5.5 p -137.7 172.79 12.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.202 -1.176 . . . . 0.0 109.545 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.1 t -108.13 82.41 1.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 277' ' ' VAL . 6.2 p -79.85 146.34 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.518 ' N ' HG21 ' A' ' 251' ' ' VAL . 0.0 OUTLIER -130.84 168.14 17.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.645 ' CB ' ' CE1' ' A' ' 267' ' ' TYR . . . -129.01 162.97 26.38 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -169.02 115.12 0.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.441 ' CG ' ' OG1' ' A' ' 325' ' ' THR . 6.4 mtm-85 -59.68 119.88 8.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.457 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -101.86 -89.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 1.7 mm-40 -84.06 165.38 18.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -170.41 149.3 3.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.373 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.472 ' O ' ' HE3' ' A' ' 319' ' ' LYS . 13.4 p90 -158.84 -168.32 2.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.419 -0.801 . . . . 0.0 109.038 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t -86.5 47.11 1.43 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.199 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . 0.435 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.5 t70 -160.23 -37.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 109.957 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.514 ' HA3' ' CG ' ' A' ' 319' ' ' LYS . . . -172.27 171.1 44.03 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.636 ' CZ ' ' CG1' ' A' ' 317' ' ' VAL . 16.8 p90 -131.58 136.22 47.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.951 -1.323 . . . . 0.0 110.061 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 38.8 t30 -79.34 111.4 15.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.584 HG12 ' CE2' ' A' ' 267' ' ' TYR . 2.8 t -92.27 147.08 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.477 -0.764 . . . . 0.0 109.328 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.528 ' N ' HG11 ' A' ' 265' ' ' VAL . 14.0 p -128.78 94.28 3.81 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.4 -0.812 . . . . 0.0 109.166 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.674 ' CD2' ' CZ ' ' A' ' 313' ' ' PHE . 37.1 m-85 -81.99 126.73 32.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 312' ' ' THR . 2.6 t -105.7 115.96 31.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.923 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.578 HG23 ' CH2' ' A' ' 275' ' ' TRP . 59.1 t -88.27 145.8 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.507 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.506 ' N ' HG11 ' A' ' 269' ' ' VAL . 2.6 m -157.64 126.04 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.0 109.411 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.9 -38.44 1.75 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.55 167.59 29.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -1.09 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 306' ' ' PRO . 2.0 m -99.55 -41.27 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -85.21 67.6 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 108.913 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.578 ' CH2' HG23 ' A' ' 269' ' ' VAL . 56.2 p-90 -110.16 173.41 6.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.496 -0.752 . . . . 0.0 109.688 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.41 112.9 7.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.53 ' CG2' HG22 ' A' ' 251' ' ' VAL . 42.8 t -96.49 101.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.52 106.57 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.908 . . . . 0.0 108.838 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 313' ' ' PHE . 13.6 mt -80.82 143.01 33.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.838 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -134.73 105.54 6.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.265 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' A' ' 287' ' ' ILE . 3.9 mm? -66.08 171.08 4.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.708 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.442 ' HB2' ' OE1' ' A' ' 285' ' ' GLN . 1.7 m-80 -118.55 153.96 33.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.65 -148.3 9.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 285' ' ' GLN . 19.5 p -80.35 5.65 14.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 109.63 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.463 ' C ' ' CG2' ' A' ' 286' ' ' THR . 75.2 mt-30 -43.88 166.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.65 174.06 15.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 109.529 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.492 ' CD1' HD22 ' A' ' 281' ' ' LEU . 17.8 mm -94.49 132.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.358 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 40.1 tt0 -106.83 -36.97 6.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.582 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -164.45 169.96 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.639 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 71.2 p -158.13 166.5 32.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.315 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.563 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 32.0 p90 -167.56 172.09 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 291' ' ' TRP . 33.5 m-20 63.3 10.87 4.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.424 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . -178.34 149.2 0.51 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -79.97 100.59 8.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 0.0 109.278 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.514 ' CG2' HG23 ' A' ' 304' ' ' VAL . 4.6 t -107.59 137.66 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.458 HG21 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER -160.08 156.42 26.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . 0.503 ' N ' ' HD2' ' A' ' 302' ' ' ARG . . . -179.07 -163.42 30.08 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.45 79.44 0.09 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.197 -1.178 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 148.32 -73.21 0.29 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.46 ' O ' HD21 ' A' ' 281' ' ' LEU . 65.5 m -153.27 -54.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -1.154 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 1.0 OUTLIER -79.51 150.44 31.16 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.227 -0.921 . . . . 0.0 109.673 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.503 ' HD2' ' N ' ' A' ' 297' ' ' GLY . 5.7 mtm180 -140.48 143.63 35.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 89.7 m -90.34 121.78 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.514 HG23 ' CG2' ' A' ' 295' ' ' VAL . 55.3 t -105.32 145.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.472 ' N ' HG11 ' A' ' 304' ' ' VAL . 0.8 OUTLIER -141.33 154.8 67.67 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.8 Cg_endo -78.12 144.46 21.06 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -93.56 -15.94 24.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.63 4.94 16.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.59 27.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -1.179 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.13 63.62 0.33 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 269' ' ' VAL . 56.5 m-20 -53.25 -31.98 46.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -1.138 . . . . 0.0 109.394 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 267' ' ' TYR . 61.4 m -97.44 123.4 41.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.674 ' CZ ' ' CD2' ' A' ' 267' ' ' TYR . 7.7 p90 -108.08 171.96 7.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.576 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.563 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -148.91 128.79 2.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 289' ' ' ALA . 13.6 m -132.45 159.18 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.9 m -92.84 110.09 21.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.636 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 46.6 t -84.19 127.23 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 1.5 mmt -79.75 103.74 9.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 108.75 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.514 ' CG ' ' HA3' ' A' ' 262' ' ' GLY . 32.6 mttt -43.03 -46.91 5.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -0.832 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 318' ' ' MET . 11.4 m-20 43.47 44.46 5.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.203 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 122.87 -51.32 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.442 ' HB3' ' OG1' ' A' ' 324' ' ' THR . 0.4 OUTLIER -138.23 140.45 39.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -1.176 . . . . 0.0 109.896 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.568 ' O ' ' CE1' ' A' ' 263' ' ' PHE . 1.1 p -81.4 6.72 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -36.09 129.14 0.69 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.608 -0.683 . . . . 0.0 111.11 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.57 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 21.0 m -69.26 144.12 94.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 24.8 Cg_endo -72.62 171.99 16.09 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.15 1.9 . . . . 0.0 111.109 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.77 149.67 23.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.581 ' HB1' ' CE1' ' A' ' 267' ' ' TYR . . . -139.58 131.97 28.48 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.975 -1.078 . . . . 0.0 109.965 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -124.36 156.1 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.53 -0.731 . . . . 0.0 109.369 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.493 ' HB2' HG13 ' A' ' 251' ' ' VAL . 48.9 t -123.97 135.44 53.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.883 . . . . 0.0 109.76 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 247' ' ' THR . . . -125.42 156.82 38.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.314 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -82.89 124.64 6.61 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.27 -1.135 . . . . 0.0 109.52 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -158.57 173.42 35.6 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 330' ' ' CYS . 11.2 p -59.72 172.07 0.78 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -1.167 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.15 81.72 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.534 ' CB ' HG23 ' A' ' 277' ' ' VAL . 6.2 p -79.27 145.82 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.505 ' N ' HG21 ' A' ' 251' ' ' VAL . 0.0 OUTLIER -134.71 170.6 15.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -118.45 164.49 15.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 109.94 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 18.2 m -167.08 104.46 0.55 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.309 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -57.65 125.17 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.704 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -103.58 -83.08 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.709 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 257' ' ' GLU . 39.0 mm-40 -97.53 168.62 10.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 0.0 109.652 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -170.41 146.62 2.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.425 ' CE2' ' O ' ' A' ' 262' ' ' GLY . 12.4 p90 -155.85 -168.46 2.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 43.0 m -84.19 45.65 1.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 110.065 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . 0.481 ' OD1' ' CE ' ' A' ' 318' ' ' MET . 2.1 t0 -159.99 -36.84 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 319' ' ' LYS . . . -174.64 170.65 43.8 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.588 ' CE1' ' HB ' ' A' ' 317' ' ' VAL . 5.6 p90 -135.43 138.0 42.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.267 . . . . 0.0 109.919 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 90.5 m-20 -79.68 99.04 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.64 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.601 ' CG1' ' CE1' ' A' ' 267' ' ' TYR . 2.3 t -81.16 147.42 6.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 108.786 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.526 ' N ' HG11 ' A' ' 265' ' ' VAL . 23.9 p -129.39 94.51 3.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.655 ' CD1' ' CZ ' ' A' ' 313' ' ' PHE . 47.9 m-85 -80.32 130.3 35.09 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.455 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.2 t -110.2 121.62 45.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.074 -1.016 . . . . 0.0 110.189 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.532 HG13 ' CD1' ' A' ' 275' ' ' TRP . 79.5 t -99.39 131.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.34 116.64 11.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.81 -38.48 0.99 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.96 165.71 35.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -1.09 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -98.17 -43.08 7.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.171 -0.955 . . . . 0.0 109.212 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -81.12 75.6 8.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.875 . . . . 0.0 108.94 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.532 ' CD1' HG13 ' A' ' 269' ' ' VAL . 48.1 p-90 -119.19 173.65 6.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.85 . . . . 0.0 109.648 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.3 m -140.64 115.08 9.38 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.408 -0.807 . . . . 0.0 108.888 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 251' ' ' VAL . 77.1 t -104.72 105.88 19.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 9.6 t30 -78.93 119.76 22.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.611 ' CD1' ' CZ ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -101.25 128.94 47.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.139 -0.976 . . . . 0.0 110.303 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -116.87 97.2 5.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 109.01 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 326' ' ' PRO . 1.1 mp -60.77 171.94 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 110.098 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.528 ' ND2' HG21 ' A' ' 324' ' ' THR . 0.3 OUTLIER -111.52 164.64 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.604 -179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 48.14 -153.42 1.88 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.4 p -88.04 17.17 5.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.514 ' OE1' ' CG1' ' A' ' 317' ' ' VAL . 8.3 mt-30 -45.33 171.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 285' ' ' GLN . 1.1 p -152.65 170.39 20.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.844 . . . . 0.0 109.572 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.48 ' CG1' ' HD3' ' A' ' 302' ' ' ARG . 19.3 mm -92.82 121.32 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.451 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 7.6 tp-100 -95.94 -35.62 11.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -163.11 166.52 23.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.612 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.408 ' CB ' HG11 ' A' ' 315' ' ' VAL . 96.6 p -156.65 168.44 27.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.382 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 24.6 p90 -169.78 170.31 7.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.699 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 52.0 m-20 61.9 12.19 4.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.511 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . -178.67 173.82 1.25 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.451 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 15.6 m-80 -107.57 101.25 10.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.33 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.515 ' CG2' HG21 ' A' ' 304' ' ' VAL . 46.1 t -106.36 126.28 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 295' ' ' VAL . 3.5 p -149.5 154.99 39.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . 0.446 ' HA2' ' HG3' ' A' ' 302' ' ' ARG . . . 162.82 -161.62 33.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.42 ' OG ' ' C ' ' A' ' 297' ' ' GLY . 0.7 OUTLIER -170.4 133.97 1.11 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.198 -1.177 . . . . 0.0 109.548 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 108.56 -73.26 0.2 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.49 -51.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -1.167 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 302' ' ' ARG . 67.1 p -79.52 160.58 26.45 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 109.605 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.48 ' HD3' ' CG1' ' A' ' 287' ' ' ILE . 0.6 OUTLIER -154.54 167.51 29.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 97.9 m -117.45 124.65 49.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.374 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.515 HG21 ' CG2' ' A' ' 295' ' ' VAL . 74.5 t -106.53 139.26 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -124.1 162.69 40.14 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.389 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -78.37 135.04 13.07 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.609 2.206 . . . . 0.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.62 -29.04 26.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.03 5.72 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.8 t -153.26 24.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.156 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -139.79 64.99 0.53 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.25 -25.41 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -1.168 . . . . 0.0 109.453 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 267' ' ' TYR . 94.7 m -106.56 127.15 53.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.655 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 8.8 p90 -112.1 172.47 6.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 265' ' ' VAL . . . -153.66 132.19 3.51 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 289' ' ' ALA . 5.4 m -140.18 152.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -1.17 . . . . 0.0 109.796 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 13.5 m -81.61 128.19 33.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 263' ' ' PHE . 58.8 t -100.37 106.07 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.793 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.481 ' CE ' ' OD1' ' A' ' 261' ' ' ASP . 2.0 mmt -60.42 97.57 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.033 -1.042 . . . . 0.0 108.682 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.512 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 30.4 mttt -42.33 -46.32 4.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.699 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 319' ' ' LYS . 28.8 m-20 43.88 46.22 6.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.254 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.35 24.41 51.26 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 285' ' ' GLN . 16.7 t -160.65 97.94 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -1.105 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.512 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 21.2 p -92.95 31.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.528 HG21 ' ND2' ' A' ' 282' ' ' ASN . 0.8 OUTLIER -90.64 146.37 24.09 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.129 -0.982 . . . . 0.0 109.134 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.568 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 18.2 m -69.05 145.61 96.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 108.988 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 24.4 Cg_endo -72.56 172.6 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.237 1.958 . . . . 0.0 110.66 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -96.62 159.96 14.65 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -156.67 132.4 9.53 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.843 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -133.18 154.84 50.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.402 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.506 ' HB2' ' CG1' ' A' ' 251' ' ' VAL . 44.4 t -110.78 148.26 32.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.86 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -160.64 170.88 19.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.463 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 102.87 -113.13 4.47 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.255 -1.144 . . . . 0.0 109.446 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 275' ' ' TRP . 2.6 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.263 0.554 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 34.4 m -121.94 84.3 2.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.271 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 269' ' ' VAL . 3.5 p -79.96 149.2 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -131.48 164.1 26.5 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.927 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -120.01 162.74 18.72 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.399 -0.813 . . . . 0.0 109.899 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 255' ' ' ARG . 15.8 m -169.64 161.69 9.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.252 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.514 ' N ' HG22 ' A' ' 254' ' ' THR . 0.6 OUTLIER -106.69 119.71 40.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.506 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -97.68 -89.84 0.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.829 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -91.75 168.63 11.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.764 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 9.0 tt0 -170.29 148.85 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -157.27 -168.93 2.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.478 -0.764 . . . . 0.0 108.957 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t -84.71 46.05 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.113 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -160.22 -36.33 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.489 ' HA2' ' HG3' ' A' ' 319' ' ' LYS . . . -172.63 171.6 44.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.571 ' CE1' ' HB ' ' A' ' 317' ' ' VAL . 5.9 p90 -134.66 137.2 43.4 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.047 -1.267 . . . . 0.0 109.84 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 77.5 m-20 -79.09 102.16 8.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.877 HG11 ' CE1' ' A' ' 267' ' ' TYR . 4.3 t -78.19 150.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.311 -0.868 . . . . 0.0 108.982 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.2 p -133.5 93.43 3.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 0.927 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 48.8 m-85 -81.32 132.4 35.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.461 ' HA ' HG23 ' A' ' 312' ' ' THR . 6.5 m -111.06 119.63 39.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.015 -1.053 . . . . 0.0 110.319 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.569 HG11 ' CG ' ' A' ' 275' ' ' TRP . 71.7 t -97.93 138.01 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.399 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.8 m -149.49 130.38 14.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 132.1 -37.31 2.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.2 m -150.89 159.85 44.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -97.17 -44.57 6.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 108.995 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -80.22 77.41 6.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 108.834 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.639 ' CE3' HG23 ' A' ' 277' ' ' VAL . 60.0 p-90 -123.75 165.39 17.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 109.544 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 330' ' ' CYS . 86.5 m -135.98 118.19 15.55 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.144 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.639 HG23 ' CE3' ' A' ' 275' ' ' TRP . 44.8 t -105.16 104.48 17.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.67 109.36 8.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 108.96 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 313' ' ' PHE . 11.8 mt -79.93 145.97 32.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.65 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.7 96.14 3.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.943 ' CD1' HG13 ' A' ' 317' ' ' VAL . 3.9 mm? -59.89 169.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.572 HD22 ' HA ' ' A' ' 326' ' ' PRO . 0.8 OUTLIER -115.57 148.54 39.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.26 -143.61 40.93 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.5 p -84.13 7.94 17.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.598 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.494 ' O ' HG22 ' A' ' 286' ' ' THR . 61.8 mt-30 -44.26 167.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 285' ' ' GLN . 1.1 p -155.89 174.89 14.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.541 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.653 HD11 HD21 ' A' ' 281' ' ' LEU . 13.9 mm -98.59 109.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 0.3 OUTLIER -85.56 -34.23 21.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -165.45 171.36 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 109.831 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' SER . . . . . 1.016 ' CB ' HG12 ' A' ' 315' ' ' VAL . 43.5 p -161.86 169.98 20.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.347 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 32.1 p90 -169.99 165.91 9.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.3 m-20 71.79 3.42 4.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 109.68 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -174.42 145.66 0.99 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.49 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -84.65 101.25 12.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.895 ' HB ' HG22 ' A' ' 304' ' ' VAL . 3.4 p -116.96 141.84 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.583 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' THR . . . . . 0.424 ' C ' ' HG2' ' A' ' 302' ' ' ARG . 19.4 p . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 121.274 0.559 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 301' ' ' THR . 4.2 mmt180 -139.03 132.24 29.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 295' ' ' VAL . 41.3 m -76.29 118.63 19.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.952 . . . . 0.0 109.503 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.895 HG22 ' HB ' ' A' ' 295' ' ' VAL . 75.6 t -101.59 149.35 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.506 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 1.2 p -146.15 148.36 34.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -77.91 138.64 16.79 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.588 2.192 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -79.98 -17.91 51.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.13 -37.15 1.43 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.21 11.06 3.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.129 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -109.93 65.14 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 7.1 m120 -58.63 -28.32 65.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -1.163 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.867 HG23 ' O ' ' A' ' 267' ' ' TYR . 88.6 m -102.01 125.58 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.702 ' CE1' HD11 ' A' ' 279' ' ' LEU . 7.0 p90 -111.47 171.46 7.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -151.34 128.68 2.64 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 1.016 HG12 ' CB ' ' A' ' 290' ' ' SER . 17.9 m -133.83 158.19 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.58 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.2 m -88.87 109.22 20.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.943 HG13 ' CD1' ' A' ' 281' ' ' LEU . 25.2 t -79.5 106.6 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 1.1 mmt -59.31 94.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.125 -0.985 . . . . 0.0 108.75 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.539 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 21.2 mttt -41.07 -45.29 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.718 . . . . 0.0 109.775 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 319' ' ' LYS . 55.0 m-20 41.06 45.4 2.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.511 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.61 29.96 28.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 319' ' ' LYS . 29.0 t -160.05 110.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -1.15 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.539 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 11.5 p -98.93 25.44 6.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.69 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.92 145.72 24.5 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.113 -0.992 . . . . 0.0 109.572 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.847 HG23 ' HD2' ' A' ' 326' ' ' PRO . 16.3 m -71.14 146.47 92.52 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.847 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.9 Cg_endo -73.42 173.37 13.92 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.169 1.913 . . . . 0.0 110.761 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.65 149.25 24.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.552 ' HB3' ' CE2' ' A' ' 267' ' ' TYR . . . -142.43 132.89 25.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.079 -1.013 . . . . 0.0 109.864 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -128.74 156.63 43.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.494 -0.753 . . . . 0.0 109.29 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 330' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 22.8 t -131.87 162.84 29.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.96 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.13 179.85 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.521 ' SG ' HG13 ' A' ' 269' ' ' VAL . 9.6 p . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.363 0.601 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.82 81.16 1.62 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.616 HG21 HG21 ' A' ' 277' ' ' VAL . 7.3 p -79.58 149.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.88 171.39 14.47 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 1.116 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -127.99 164.91 21.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -168.55 107.06 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.451 ' HG2' ' OG1' ' A' ' 325' ' ' THR . 1.3 mmm180 -48.97 123.39 7.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -105.41 -90.38 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.706 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 4.3 mm-40 -88.03 165.62 15.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 109.549 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 84.6 tt0 -170.35 155.82 5.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' TRP . . . . . 0.441 ' N ' ' HG2' ' A' ' 258' ' ' GLU . 11.7 p90 -163.01 -168.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 t -84.34 43.33 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.2 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 319' ' ' LYS . 3.1 t70 -155.68 -38.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.783 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.482 ' O ' ' HE3' ' A' ' 319' ' ' LYS . . . -167.92 -169.08 30.96 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.563 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 31.9 p90 -152.21 128.67 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -1.235 . . . . 0.0 109.894 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 10.0 t30 -79.59 113.18 17.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.82 . . . . 0.0 109.608 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.927 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -92.09 148.16 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 0.0 109.111 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 23.1 p -126.77 95.36 4.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.354 -0.841 . . . . 0.0 109.246 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 1.116 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 42.4 m-85 -80.99 130.84 35.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 108.765 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.456 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.3 p -109.17 119.55 39.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.082 -1.012 . . . . 0.0 110.022 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.642 HG11 ' CD1' ' A' ' 275' ' ' TRP . 79.2 t -92.85 135.62 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.52 116.08 7.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 149.12 -39.17 0.94 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.12 168.58 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -1.118 . . . . 0.0 109.42 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -42.13 7.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.891 . . . . 0.0 109.23 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.64 71.41 10.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 108.868 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.75 ' CE3' HG23 ' A' ' 277' ' ' VAL . 56.7 p-90 -115.81 172.4 7.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 0.0 109.656 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 83.6 m -141.36 108.54 5.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.313 -0.867 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.75 HG23 ' CE3' ' A' ' 275' ' ' TRP . 46.7 t -91.63 103.29 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.354 -0.841 . . . . 0.0 109.906 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.17 111.23 8.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 108.904 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.691 HD23 ' CG2' ' A' ' 304' ' ' VAL . 3.9 mm? -80.09 145.93 32.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.845 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.81 92.53 2.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.221 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.706 HD13 ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -59.93 165.62 3.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.567 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.414 ' OD1' HG22 ' A' ' 324' ' ' THR . 0.8 OUTLIER -110.33 150.65 28.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 56.81 -128.42 46.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.3 m -112.04 30.13 7.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.746 ' OE1' HG12 ' A' ' 317' ' ' VAL . 9.8 mt-30 -62.75 171.83 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.895 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.1 p -149.83 177.04 10.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.491 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.548 HG13 ' CD ' ' A' ' 302' ' ' ARG . 10.1 mm -103.59 131.19 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.281 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.532 ' HG3' ' CG ' ' A' ' 318' ' ' MET . 0.1 OUTLIER -103.41 -38.75 7.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.467 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 315' ' ' VAL . . . -154.63 164.81 38.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.804 ' CB ' HG12 ' A' ' 315' ' ' VAL . 14.6 m -158.13 164.01 37.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.501 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 31.2 p90 -166.74 165.47 16.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.4 m-20 71.7 3.39 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -175.74 148.29 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.154 -0.966 . . . . 0.0 109.592 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.466 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 38.7 m-80 -84.29 101.87 12.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 304' ' ' VAL . 25.7 t -104.37 133.62 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.578 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 302' ' ' ARG . 5.1 p . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 302' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 121.337 0.589 . . . . 0.0 109.572 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.548 ' CD ' HG13 ' A' ' 287' ' ' ILE . 45.5 mtt85 -156.09 168.93 25.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 22.9 m -121.59 121.3 37.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 295' ' ' VAL . 70.8 t -106.68 142.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.521 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.603 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.8 OUTLIER -129.71 160.33 65.3 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.421 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.5 Cg_endo -78.21 131.22 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.61 2.207 . . . . 0.0 110.347 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.01 -25.65 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.08 -42.27 1.06 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.35 11.48 2.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.495 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -110.24 65.33 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 70.3 m-20 -54.94 -24.21 22.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -1.174 . . . . 0.0 109.49 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 267' ' ' TYR . 87.6 m -106.56 124.08 49.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.653 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 7.4 p90 -109.92 172.22 6.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.556 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -151.62 129.51 2.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.804 HG12 ' CB ' ' A' ' 290' ' ' SER . 7.1 m -135.84 157.04 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -1.123 . . . . 0.0 109.656 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 14.6 m -89.74 107.24 18.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.33 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.746 HG12 ' OE1' ' A' ' 285' ' ' GLN . 22.2 t -79.58 106.7 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.701 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.532 ' CG ' ' HG3' ' A' ' 288' ' ' GLN . 0.2 OUTLIER -59.56 108.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.12 -0.988 . . . . 0.0 108.787 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.551 ' HG2' ' CA ' ' A' ' 323' ' ' SER . 4.6 mttm -43.63 -51.31 7.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 45.98 47.02 12.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 78.56 24.08 63.59 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.6 OUTLIER -161.16 102.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -1.118 . . . . 0.0 109.473 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.551 ' CA ' ' HG2' ' A' ' 319' ' ' LYS . 80.0 p -98.11 27.91 4.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.965 . . . . 0.0 109.707 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' THR . . . . . 0.414 HG22 ' OD1' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.5 141.93 28.25 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.162 -0.962 . . . . 0.0 109.109 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.811 HG23 ' HD2' ' A' ' 326' ' ' PRO . 20.1 m -64.46 144.77 98.6 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.005 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.8 Cg_endo -73.73 173.32 14.14 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.328 2.019 . . . . 0.0 110.882 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.85 148.67 24.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.632 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -141.0 132.64 27.17 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.106 -0.996 . . . . 0.0 109.819 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -126.87 155.77 42.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.393 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 330' ' ' CYS . . . . . 0.545 ' HB2' HG12 ' A' ' 251' ' ' VAL . 49.3 t -122.91 149.91 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.319 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.543 ' SG ' HG13 ' A' ' 269' ' ' VAL . 10.3 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.329 0.585 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.48 82.48 1.67 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.314 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.595 HG21 ' CG2' ' A' ' 277' ' ' VAL . 6.6 p -79.76 146.04 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.721 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -129.94 171.07 13.15 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 1.078 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -126.47 161.08 28.75 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 54.2 m -164.68 112.17 1.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.264 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.458 ' HD2' ' OG1' ' A' ' 325' ' ' THR . 5.9 mtp-105 -60.57 120.46 10.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.562 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.63 -92.94 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.62 164.89 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 109.595 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.5 OUTLIER -170.46 153.12 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' TRP . . . . . 0.486 ' O ' ' NZ ' ' A' ' 319' ' ' LYS . 11.7 p90 -161.21 -169.27 2.27 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 17.0 m -84.13 44.56 1.02 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.102 -0.999 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ASP . . . . . 0.434 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.2 t70 -159.57 -35.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.535 ' HA2' ' CG ' ' A' ' 319' ' ' LYS . . . -170.28 178.82 42.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.907 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 12.6 p90 -144.27 133.02 22.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.144 -1.21 . . . . 0.0 109.924 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -79.53 103.49 9.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.931 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.3 t -81.74 147.46 6.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 108.972 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.7 p -126.87 95.4 4.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.323 -0.861 . . . . 0.0 109.174 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 1.078 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 43.6 m-85 -82.33 129.82 34.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.525 ' HA ' HG23 ' A' ' 312' ' ' THR . 0.7 OUTLIER -108.98 116.2 31.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.084 -1.01 . . . . 0.0 110.032 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.664 HG21 ' CH2' ' A' ' 275' ' ' TRP . 89.5 t -88.19 142.53 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.7 t -154.76 126.65 7.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.453 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.16 -38.49 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.46 166.09 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -1.099 . . . . 0.0 109.456 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.05 -41.28 7.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.179 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.86 70.91 10.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 108.951 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.784 ' CE3' HG23 ' A' ' 277' ' ' VAL . 57.7 p-90 -115.57 173.19 6.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 46.2 m -142.6 105.55 4.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.399 -0.813 . . . . 0.0 109.102 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.784 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.3 t -86.25 96.22 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.339 -0.85 . . . . 0.0 109.813 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -67.23 105.72 1.81 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 108.821 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.53 HD11 ' CZ ' ' A' ' 313' ' ' PHE . 12.6 mt -80.03 143.36 34.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -135.44 92.67 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.293 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -60.01 163.62 4.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.445 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 0.8 OUTLIER -111.02 153.97 24.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.417 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.78 -147.57 14.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 285' ' ' GLN . 6.2 m -89.53 19.6 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -1.14 . . . . 0.0 109.467 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.47 ' OE1' ' CG1' ' A' ' 317' ' ' VAL . 67.7 mt-30 -46.99 173.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.308 -0.87 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.464 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.95 163.21 40.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' A' ' 287' ' ' ILE . 17.7 mm -102.18 108.29 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.827 . . . . 0.0 109.145 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.484 ' HB2' ' SD ' ' A' ' 318' ' ' MET . 7.8 tm0? -83.06 -34.76 26.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.969 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -152.81 171.8 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.193 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.879 ' CB ' HG12 ' A' ' 315' ' ' VAL . 15.2 m -167.82 165.1 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.519 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 29.4 p90 -168.67 170.37 9.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 109.909 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.529 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 1.8 m-20 69.95 4.61 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.784 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.756 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -178.07 148.37 0.5 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.183 -0.948 . . . . 0.0 109.623 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 11.8 m-80 -86.44 100.59 12.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.897 . . . . 0.0 109.308 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 304' ' ' VAL . 3.0 p -114.88 139.71 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 295' ' ' VAL . 1.1 p . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 109.516 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 121.28 0.562 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.418 ' HB3' ' C ' ' A' ' 296' ' ' THR . 10.9 mtt180 -139.37 134.22 32.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 48.8 m -80.37 123.89 28.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.559 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 295' ' ' VAL . 79.5 t -99.3 142.69 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.756 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.9 OUTLIER -128.83 162.98 48.41 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 305' ' ' THR . 35.5 Cg_endo -78.01 133.28 12.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.597 2.198 . . . . 0.0 110.368 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -80.02 -32.47 39.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 148.49 -33.57 1.19 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.8 t -150.72 18.55 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -1.143 . . . . 0.0 109.458 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -120.81 65.17 0.46 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -51.08 -28.67 11.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -1.157 . . . . 0.0 109.478 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 267' ' ' TYR . 66.3 m -101.08 123.92 45.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' A' ' 267' ' ' TYR . 6.3 p90 -109.82 170.91 7.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -149.15 127.67 2.55 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.879 HG12 ' CB ' ' A' ' 290' ' ' SER . 5.9 m -134.13 152.15 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 109.828 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.462 ' HB ' ' OE1' ' A' ' 288' ' ' GLN . 18.9 m -82.22 134.39 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.057 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 85.6 t -107.88 124.95 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 288' ' ' GLN . 0.0 OUTLIER -83.19 95.68 8.2 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.106 -0.996 . . . . 0.0 108.523 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.552 ' HD3' ' CB ' ' A' ' 323' ' ' SER . 11.9 mttt -42.59 -47.13 5.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.458 -0.776 . . . . 0.0 109.836 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 319' ' ' LYS . 93.2 m-20 42.76 43.92 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 92.32 20.65 34.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 13.9 m -160.15 99.99 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -1.182 . . . . 0.0 109.58 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.552 ' CB ' ' HD3' ' A' ' 319' ' ' LYS . 61.5 p -93.29 29.8 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.89 143.49 26.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.146 -0.971 . . . . 0.0 109.482 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.879 HG23 ' HD2' ' A' ' 326' ' ' PRO . 16.2 m -68.47 146.52 97.83 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.879 ' HD2' HG23 ' A' ' 325' ' ' THR . 25.3 Cg_endo -73.25 172.6 15.25 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.249 1.966 . . . . 0.0 110.88 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.53 148.69 24.51 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.651 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -140.46 132.39 27.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 109.623 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -127.63 155.85 43.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 109.722 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 330' ' ' CYS . . . . . 0.488 ' HB2' HG12 ' A' ' 251' ' ' VAL . 43.9 t -124.22 152.87 42.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.588 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.491 ' SG ' HG13 ' A' ' 269' ' ' VAL . 5.5 p . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.362 0.601 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.1 t -108.13 82.41 1.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.521 HG21 ' CG2' ' A' ' 277' ' ' VAL . 6.2 p -79.85 146.34 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -130.84 168.14 17.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 1.071 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -129.01 162.97 26.38 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -169.02 115.12 0.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.441 ' CG ' ' OG1' ' A' ' 325' ' ' THR . 6.4 mtm-85 -59.68 119.88 8.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.457 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -101.86 -89.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 1.7 mm-40 -84.06 165.38 18.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -170.41 149.3 3.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.373 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 259' ' ' TRP . . . . . 0.458 ' O ' ' HE3' ' A' ' 319' ' ' LYS . 13.4 p90 -158.84 -168.32 2.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.419 -0.801 . . . . 0.0 109.038 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t -86.5 47.11 1.43 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.199 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ASP . . . . . 0.444 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.5 t70 -160.23 -37.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 109.957 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 319' ' ' LYS . . . -172.27 171.1 44.03 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.763 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 16.8 p90 -131.58 136.22 47.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.951 -1.323 . . . . 0.0 110.061 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 38.8 t30 -79.34 111.4 15.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.895 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.8 t -92.27 147.08 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.477 -0.764 . . . . 0.0 109.328 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.0 p -128.78 94.28 3.81 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.4 -0.812 . . . . 0.0 109.166 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 1.071 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 37.1 m-85 -81.99 126.73 32.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 312' ' ' THR . 2.6 t -105.7 115.96 31.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.923 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.671 HG11 ' CG ' ' A' ' 275' ' ' TRP . 59.1 t -88.27 145.8 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.507 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.6 m -157.64 126.04 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.9 -38.44 1.75 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.55 167.59 29.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -1.09 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 306' ' ' PRO . 2.0 m -99.55 -41.27 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -85.21 67.6 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 108.913 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.75 ' CE3' HG23 ' A' ' 277' ' ' VAL . 56.2 p-90 -110.16 173.41 6.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.496 -0.752 . . . . 0.0 109.688 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.41 112.9 7.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.75 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.8 t -96.49 101.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.52 106.57 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.908 . . . . 0.0 108.838 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.744 HD11 ' CE1' ' A' ' 313' ' ' PHE . 13.6 mt -80.82 143.01 33.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.838 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -134.73 105.54 6.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.265 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.764 HD12 HG13 ' A' ' 317' ' ' VAL . 3.9 mm? -66.08 171.08 4.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.708 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.474 HD22 ' HA ' ' A' ' 326' ' ' PRO . 1.1 m120 -118.55 153.96 33.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.65 -148.3 9.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 285' ' ' GLN . 19.5 p -80.35 5.65 14.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 109.63 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.463 ' C ' ' CG2' ' A' ' 286' ' ' THR . 75.2 mt-30 -43.88 166.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.65 174.06 15.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 109.529 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.659 HG21 ' CZ ' ' A' ' 302' ' ' ARG . 17.8 mm -94.49 132.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.358 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.449 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 40.1 tt0 -106.83 -36.97 6.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.582 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -164.45 169.96 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.639 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.779 ' CB ' HG12 ' A' ' 315' ' ' VAL . 71.2 p -158.13 166.5 32.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.315 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.563 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 32.0 p90 -167.56 172.09 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 33.5 m-20 63.3 10.87 4.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -178.34 149.2 0.51 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -79.97 100.59 8.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 0.0 109.278 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.738 HG13 HG22 ' A' ' 304' ' ' VAL . 4.6 t -107.59 137.66 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.244 0.545 . . . . 0.0 109.673 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.659 ' CZ ' HG21 ' A' ' 287' ' ' ILE . 5.7 mtm180 -140.48 143.63 35.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 89.7 m -90.34 121.78 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.738 HG22 HG13 ' A' ' 295' ' ' VAL . 55.3 t -105.32 145.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.476 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.8 OUTLIER -141.33 154.8 67.67 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.8 Cg_endo -78.12 144.46 21.06 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -93.56 -15.94 24.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.63 4.94 16.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.59 27.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -1.179 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.13 63.62 0.33 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASN . . . . . 0.457 ' HB3' ' HB ' ' A' ' 269' ' ' VAL . 56.5 m-20 -53.25 -31.98 46.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -1.138 . . . . 0.0 109.394 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 267' ' ' TYR . 61.4 m -97.44 123.4 41.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.744 ' CE1' HD11 ' A' ' 279' ' ' LEU . 7.7 p90 -108.08 171.96 7.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.576 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.563 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -148.91 128.79 2.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.779 HG12 ' CB ' ' A' ' 290' ' ' SER . 13.6 m -132.45 159.18 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.9 m -92.84 110.09 21.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.764 HG13 HD12 ' A' ' 281' ' ' LEU . 46.6 t -84.19 127.23 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.461 ' HB3' ' OD1' ' A' ' 320' ' ' ASN . 1.5 mmt -79.75 103.74 9.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 108.75 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.503 ' CG ' ' HA2' ' A' ' 262' ' ' GLY . 32.6 mttt -43.03 -46.91 5.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -0.832 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 318' ' ' MET . 11.4 m-20 43.47 44.46 5.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.203 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 122.87 -51.32 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' SER . . . . . 0.443 ' HB3' ' OG1' ' A' ' 324' ' ' THR . 0.4 OUTLIER -138.23 140.45 39.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -1.176 . . . . 0.0 109.896 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.568 ' O ' ' CE1' ' A' ' 263' ' ' PHE . 1.1 p -81.4 6.72 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -36.09 129.14 0.69 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.608 -0.683 . . . . 0.0 111.11 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.798 HG23 ' HD2' ' A' ' 326' ' ' PRO . 21.0 m -69.26 144.12 94.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.798 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.8 Cg_endo -72.62 171.99 16.09 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.15 1.9 . . . . 0.0 111.109 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.77 149.67 23.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.639 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -139.58 131.97 28.48 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.975 -1.078 . . . . 0.0 109.965 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -124.36 156.1 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.53 -0.731 . . . . 0.0 109.369 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 330' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 48.9 t -123.97 135.44 53.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.883 . . . . 0.0 109.76 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.314 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 11.2 p . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.271 0.558 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.15 81.72 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.756 HG12 ' HB2' ' A' ' 330' ' ' CYS . 6.2 p -79.27 145.82 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.71 170.6 15.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 1.046 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -118.45 164.49 15.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 109.94 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 18.2 m -167.08 104.46 0.55 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.309 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -57.65 125.17 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.704 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -103.58 -83.08 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.709 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 257' ' ' GLU . 39.0 mm-40 -97.53 168.62 10.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 0.0 109.652 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -170.41 146.62 2.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 259' ' ' TRP . . . . . 0.425 ' CE2' ' O ' ' A' ' 262' ' ' GLY . 12.4 p90 -155.85 -168.46 2.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 43.0 m -84.19 45.65 1.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 110.065 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ASP . . . . . 0.481 ' OD1' ' CE ' ' A' ' 318' ' ' MET . 2.1 t0 -159.99 -36.84 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 317' ' ' VAL . . . -174.64 170.65 43.8 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.654 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 5.6 p90 -135.43 138.0 42.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.267 . . . . 0.0 109.919 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.559 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 90.5 m-20 -79.68 99.04 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.64 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.876 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.3 t -81.16 147.42 6.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 108.786 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 23.9 p -129.39 94.51 3.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 1.046 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 47.9 m-85 -80.32 130.3 35.09 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.458 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.2 t -110.2 121.62 45.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.074 -1.016 . . . . 0.0 110.189 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 251' ' ' VAL . 79.5 t -99.39 131.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.34 116.64 11.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.81 -38.48 0.99 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.96 165.71 35.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -1.09 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -98.17 -43.08 7.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.171 -0.955 . . . . 0.0 109.212 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -81.12 75.6 8.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.875 . . . . 0.0 108.94 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.723 ' CE3' HG23 ' A' ' 277' ' ' VAL . 48.1 p-90 -119.19 173.65 6.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.85 . . . . 0.0 109.648 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.3 m -140.64 115.08 9.38 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.408 -0.807 . . . . 0.0 108.888 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.723 HG23 ' CE3' ' A' ' 275' ' ' TRP . 77.1 t -104.72 105.88 19.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 9.6 t30 -78.93 119.76 22.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 1.055 HD11 ' CZ ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -101.25 128.94 47.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.139 -0.976 . . . . 0.0 110.303 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -116.87 97.2 5.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 109.01 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.808 ' CD2' HG13 ' A' ' 317' ' ' VAL . 1.1 mp -60.77 171.94 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 110.098 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 0.6 OUTLIER -111.52 164.64 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.604 -179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 48.14 -153.42 1.88 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.4 p -88.04 17.17 5.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.993 ' OE1' HG12 ' A' ' 317' ' ' VAL . 8.3 mt-30 -45.33 171.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.452 ' HA ' ' NH2' ' A' ' 302' ' ' ARG . 1.1 p -152.65 170.39 20.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.844 . . . . 0.0 109.572 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.475 ' CG1' ' HD3' ' A' ' 302' ' ' ARG . 19.3 mm -92.82 121.32 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 7.6 tp-100 -95.94 -35.62 11.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -163.11 166.52 23.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.612 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.752 ' CB ' HG12 ' A' ' 315' ' ' VAL . 96.6 p -156.65 168.44 27.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.382 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 24.6 p90 -169.78 170.31 7.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.699 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 52.0 m-20 61.9 12.19 4.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -178.67 173.82 1.25 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.472 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 15.6 m-80 -107.57 101.25 10.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.33 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 1.088 HG22 HG22 ' A' ' 304' ' ' VAL . 46.1 t -106.36 126.28 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 301' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 302' ' ' ARG . 67.1 p . . . . . 0 N--CA 1.483 1.206 0 CA-C-O 121.189 0.519 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.475 ' HD3' ' CG1' ' A' ' 287' ' ' ILE . 0.6 OUTLIER -154.54 167.51 29.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 97.9 m -117.45 124.65 49.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.374 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 1.088 HG22 HG22 ' A' ' 295' ' ' VAL . 74.5 t -106.53 139.26 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -124.1 162.69 40.14 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.389 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -78.37 135.04 13.07 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.609 2.206 . . . . 0.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.62 -29.04 26.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.03 5.72 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.8 t -153.26 24.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.156 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -139.79 64.99 0.53 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -52.25 -25.41 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -1.168 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 267' ' ' TYR . 94.7 m -106.56 127.15 53.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 1.055 ' CZ ' HD11 ' A' ' 279' ' ' LEU . 8.8 p90 -112.1 172.47 6.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -153.66 132.19 3.51 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.752 HG12 ' CB ' ' A' ' 290' ' ' SER . 5.4 m -140.18 152.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -1.17 . . . . 0.0 109.796 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 13.5 m -81.61 128.19 33.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.993 HG12 ' OE1' ' A' ' 285' ' ' GLN . 58.8 t -100.37 106.07 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.793 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.481 ' CE ' ' OD1' ' A' ' 261' ' ' ASP . 2.0 mmt -60.42 97.57 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.033 -1.042 . . . . 0.0 108.682 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.536 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 30.4 mttt -42.33 -46.32 4.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.699 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 319' ' ' LYS . 28.8 m-20 43.88 46.22 6.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.254 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.35 24.41 51.26 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 285' ' ' GLN . 16.7 t -160.65 97.94 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -1.105 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.536 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 21.2 p -92.95 31.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' THR . . . . . 0.418 HG22 ' OD1' ' A' ' 282' ' ' ASN . 0.8 OUTLIER -90.64 146.37 24.09 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.129 -0.982 . . . . 0.0 109.134 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.827 HG23 ' HD2' ' A' ' 326' ' ' PRO . 18.2 m -69.05 145.61 96.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 108.988 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.827 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.4 Cg_endo -72.56 172.6 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.237 1.958 . . . . 0.0 110.66 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -96.62 159.96 14.65 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -156.67 132.4 9.53 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.843 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -133.18 154.84 50.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.402 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 330' ' ' CYS . . . . . 0.756 ' HB2' HG12 ' A' ' 251' ' ' VAL . 44.4 t -110.78 148.26 32.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.86 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.463 -179.903 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -171.51 99.36 0.14 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 275' ' ' TRP . 2.6 p -59.87 147.55 38.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -1.144 . . . . 0.0 109.53 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 34.4 m -121.94 84.3 2.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.271 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 269' ' ' VAL . 3.5 p -79.96 149.2 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -131.48 164.1 26.5 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.927 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -120.01 162.74 18.72 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.399 -0.813 . . . . 0.0 109.899 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 255' ' ' ARG . 15.8 m -169.64 161.69 9.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.252 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.514 ' N ' HG22 ' A' ' 254' ' ' THR . 0.6 OUTLIER -106.69 119.71 40.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.506 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -97.68 -89.84 0.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.829 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -91.75 168.63 11.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.764 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 9.0 tt0 -170.29 148.85 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -157.27 -168.93 2.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.478 -0.764 . . . . 0.0 108.957 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t -84.71 46.05 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.113 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -160.22 -36.33 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.489 ' HA2' ' HG3' ' A' ' 319' ' ' LYS . . . -172.63 171.6 44.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.571 ' CE1' ' HB ' ' A' ' 317' ' ' VAL . 5.9 p90 -134.66 137.2 43.4 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.047 -1.267 . . . . 0.0 109.84 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 77.5 m-20 -79.09 102.16 8.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.877 HG11 ' CE1' ' A' ' 267' ' ' TYR . 4.3 t -78.19 150.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.311 -0.868 . . . . 0.0 108.982 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.2 p -133.5 93.43 3.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 0.927 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 48.8 m-85 -81.32 132.4 35.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.461 ' HA ' HG23 ' A' ' 312' ' ' THR . 6.5 m -111.06 119.63 39.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.015 -1.053 . . . . 0.0 110.319 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.569 HG11 ' CG ' ' A' ' 275' ' ' TRP . 71.7 t -97.93 138.01 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.399 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.8 m -149.49 130.38 14.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 132.1 -37.31 2.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.2 m -150.89 159.85 44.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -97.17 -44.57 6.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 108.995 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -80.22 77.41 6.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 108.834 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.639 ' CE3' HG23 ' A' ' 277' ' ' VAL . 60.0 p-90 -123.75 165.39 17.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 109.544 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 330' ' ' CYS . 86.5 m -135.98 118.19 15.55 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.144 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.639 HG23 ' CE3' ' A' ' 275' ' ' TRP . 44.8 t -105.16 104.48 17.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.67 109.36 8.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 108.96 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 313' ' ' PHE . 11.8 mt -79.93 145.97 32.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.65 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.7 96.14 3.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.943 ' CD1' HG13 ' A' ' 317' ' ' VAL . 3.9 mm? -59.89 169.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.572 HD22 ' HA ' ' A' ' 326' ' ' PRO . 0.8 OUTLIER -115.57 148.54 39.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.26 -143.61 40.93 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.5 p -84.13 7.94 17.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.598 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.494 ' O ' HG22 ' A' ' 286' ' ' THR . 61.8 mt-30 -44.26 167.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 285' ' ' GLN . 1.1 p -155.89 174.89 14.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.541 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.653 HD11 HD21 ' A' ' 281' ' ' LEU . 13.9 mm -98.59 109.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 0.3 OUTLIER -85.56 -34.23 21.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -165.45 171.36 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 109.831 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . 1.016 ' CB ' HG12 ' A' ' 315' ' ' VAL . 43.5 p -161.86 169.98 20.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.347 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 32.1 p90 -169.99 165.91 9.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.3 m-20 71.79 3.42 4.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 109.68 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -174.42 145.66 0.99 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.49 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -84.65 101.25 12.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.895 ' HB ' HG22 ' A' ' 304' ' ' VAL . 3.4 p -116.96 141.84 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER -160.15 170.8 20.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.583 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 302' ' ' ARG . . . 168.22 -163.92 37.57 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.48 49.39 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.227 -1.161 . . . . 0.0 109.508 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -167.1 -114.64 0.3 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 301' ' ' THR . 2.7 m -117.8 20.66 13.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -1.16 . . . . 0.0 109.417 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 300' ' ' SER . 19.4 p -160.61 156.11 25.14 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.535 ' HD3' ' CA ' ' A' ' 297' ' ' GLY . 4.2 mmt180 -139.03 132.24 29.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 295' ' ' VAL . 41.3 m -76.29 118.63 19.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.952 . . . . 0.0 109.503 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.895 HG22 ' HB ' ' A' ' 295' ' ' VAL . 75.6 t -101.59 149.35 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.506 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 1.2 p -146.15 148.36 34.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -77.91 138.64 16.79 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.588 2.192 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -79.98 -17.91 51.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.13 -37.15 1.43 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.21 11.06 3.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.129 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -109.93 65.14 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 7.1 m120 -58.63 -28.32 65.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -1.163 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.867 HG23 ' O ' ' A' ' 267' ' ' TYR . 88.6 m -102.01 125.58 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.702 ' CE1' HD11 ' A' ' 279' ' ' LEU . 7.0 p90 -111.47 171.46 7.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -151.34 128.68 2.64 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 1.016 HG12 ' CB ' ' A' ' 290' ' ' SER . 17.9 m -133.83 158.19 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.58 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.2 m -88.87 109.22 20.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.943 HG13 ' CD1' ' A' ' 281' ' ' LEU . 25.2 t -79.5 106.6 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 1.1 mmt -59.31 94.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.125 -0.985 . . . . 0.0 108.75 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.539 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 21.2 mttt -41.07 -45.29 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.718 . . . . 0.0 109.775 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 319' ' ' LYS . 55.0 m-20 41.06 45.4 2.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.511 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.61 29.96 28.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 319' ' ' LYS . 29.0 t -160.05 110.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -1.15 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.539 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 11.5 p -98.93 25.44 6.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.69 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.92 145.72 24.5 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.113 -0.992 . . . . 0.0 109.572 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.847 HG23 ' HD2' ' A' ' 326' ' ' PRO . 16.3 m -71.14 146.47 92.52 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.847 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.9 Cg_endo -73.42 173.37 13.92 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.169 1.913 . . . . 0.0 110.761 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.65 149.25 24.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.552 ' HB3' ' CE2' ' A' ' 267' ' ' TYR . . . -142.43 132.89 25.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.079 -1.013 . . . . 0.0 109.864 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -128.74 156.63 43.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.494 -0.753 . . . . 0.0 109.29 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 22.8 t -131.87 162.84 29.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.96 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -149.69 149.89 31.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.13 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -81.57 111.13 3.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.336 -1.097 . . . . 0.0 109.498 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.437 ' C ' ' HA ' ' A' ' 331' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -162.9 -129.71 1.05 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.521 ' SG ' HG13 ' A' ' 269' ' ' VAL . 9.6 p -60.3 171.74 0.98 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.247 -1.149 . . . . 0.0 109.544 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.82 81.16 1.62 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.616 HG21 HG21 ' A' ' 277' ' ' VAL . 7.3 p -79.58 149.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.88 171.39 14.47 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 1.116 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -127.99 164.91 21.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -168.55 107.06 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.451 ' HG2' ' OG1' ' A' ' 325' ' ' THR . 1.3 mmm180 -48.97 123.39 7.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -105.41 -90.38 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.706 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 4.3 mm-40 -88.03 165.62 15.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 109.549 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 84.6 tt0 -170.35 155.82 5.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.441 ' N ' ' HG2' ' A' ' 258' ' ' GLU . 11.7 p90 -163.01 -168.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 t -84.34 43.33 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.2 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 319' ' ' LYS . 3.1 t70 -155.68 -38.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.783 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.482 ' O ' ' HE3' ' A' ' 319' ' ' LYS . . . -167.92 -169.08 30.96 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.563 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 31.9 p90 -152.21 128.67 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -1.235 . . . . 0.0 109.894 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 10.0 t30 -79.59 113.18 17.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.82 . . . . 0.0 109.608 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.927 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -92.09 148.16 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 0.0 109.111 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 23.1 p -126.77 95.36 4.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.354 -0.841 . . . . 0.0 109.246 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 1.116 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 42.4 m-85 -80.99 130.84 35.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 108.765 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.456 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.3 p -109.17 119.55 39.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.082 -1.012 . . . . 0.0 110.022 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.642 HG11 ' CD1' ' A' ' 275' ' ' TRP . 79.2 t -92.85 135.62 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.52 116.08 7.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 149.12 -39.17 0.94 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.12 168.58 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -1.118 . . . . 0.0 109.42 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -42.13 7.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.891 . . . . 0.0 109.23 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.64 71.41 10.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 108.868 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.75 ' CE3' HG23 ' A' ' 277' ' ' VAL . 56.7 p-90 -115.81 172.4 7.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 0.0 109.656 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 83.6 m -141.36 108.54 5.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.313 -0.867 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.75 HG23 ' CE3' ' A' ' 275' ' ' TRP . 46.7 t -91.63 103.29 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.354 -0.841 . . . . 0.0 109.906 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.17 111.23 8.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 108.904 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.691 HD23 ' CG2' ' A' ' 304' ' ' VAL . 3.9 mm? -80.09 145.93 32.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.845 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.81 92.53 2.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.221 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.706 HD13 ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -59.93 165.62 3.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.567 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.414 ' OD1' HG22 ' A' ' 324' ' ' THR . 0.8 OUTLIER -110.33 150.65 28.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 56.81 -128.42 46.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.3 m -112.04 30.13 7.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.746 ' OE1' HG12 ' A' ' 317' ' ' VAL . 9.8 mt-30 -62.75 171.83 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.895 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.1 p -149.83 177.04 10.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.491 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.548 HG13 ' CD ' ' A' ' 302' ' ' ARG . 10.1 mm -103.59 131.19 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.281 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.532 ' HG3' ' CG ' ' A' ' 318' ' ' MET . 0.1 OUTLIER -103.41 -38.75 7.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.467 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 315' ' ' VAL . . . -154.63 164.81 38.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.804 ' CB ' HG12 ' A' ' 315' ' ' VAL . 14.6 m -158.13 164.01 37.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.501 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 31.2 p90 -166.74 165.47 16.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.4 m-20 71.7 3.39 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -175.74 148.29 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.154 -0.966 . . . . 0.0 109.592 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.466 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 38.7 m-80 -84.29 101.87 12.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 304' ' ' VAL . 25.7 t -104.37 133.62 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.578 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 302' ' ' ARG . 5.1 p -112.9 153.83 27.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.479 ' HA2' ' NE ' ' A' ' 302' ' ' ARG . . . -93.48 163.43 26.22 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.54 58.59 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.301 -1.117 . . . . 0.0 109.419 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.42 -91.21 1.45 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.63 -48.92 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -1.134 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 302' ' ' ARG . 0.8 OUTLIER -79.53 172.77 13.34 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.548 ' CD ' HG13 ' A' ' 287' ' ' ILE . 45.5 mtt85 -156.09 168.93 25.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 22.9 m -121.59 121.3 37.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 295' ' ' VAL . 70.8 t -106.68 142.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.521 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.603 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.8 OUTLIER -129.71 160.33 65.3 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.421 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.5 Cg_endo -78.21 131.22 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.61 2.207 . . . . 0.0 110.347 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.01 -25.65 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.08 -42.27 1.06 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.35 11.48 2.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.495 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -110.24 65.33 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 70.3 m-20 -54.94 -24.21 22.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -1.174 . . . . 0.0 109.49 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 267' ' ' TYR . 87.6 m -106.56 124.08 49.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.653 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 7.4 p90 -109.92 172.22 6.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.556 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -151.62 129.51 2.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.804 HG12 ' CB ' ' A' ' 290' ' ' SER . 7.1 m -135.84 157.04 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -1.123 . . . . 0.0 109.656 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 14.6 m -89.74 107.24 18.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.33 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.746 HG12 ' OE1' ' A' ' 285' ' ' GLN . 22.2 t -79.58 106.7 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.701 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.532 ' CG ' ' HG3' ' A' ' 288' ' ' GLN . 0.2 OUTLIER -59.56 108.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.12 -0.988 . . . . 0.0 108.787 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.551 ' HG2' ' CA ' ' A' ' 323' ' ' SER . 4.6 mttm -43.63 -51.31 7.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 45.98 47.02 12.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 78.56 24.08 63.59 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.6 OUTLIER -161.16 102.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -1.118 . . . . 0.0 109.473 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.551 ' CA ' ' HG2' ' A' ' 319' ' ' LYS . 80.0 p -98.11 27.91 4.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.965 . . . . 0.0 109.707 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' THR . . . . . 0.414 HG22 ' OD1' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.5 141.93 28.25 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.162 -0.962 . . . . 0.0 109.109 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.811 HG23 ' HD2' ' A' ' 326' ' ' PRO . 20.1 m -64.46 144.77 98.6 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.005 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.8 Cg_endo -73.73 173.32 14.14 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.328 2.019 . . . . 0.0 110.882 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.85 148.67 24.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.632 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -141.0 132.64 27.17 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.106 -0.996 . . . . 0.0 109.819 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -126.87 155.77 42.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.393 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.545 ' HB2' HG12 ' A' ' 251' ' ' VAL . 49.3 t -122.91 149.91 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.437 ' HA ' ' C ' ' A' ' 247' ' ' THR . . . -149.03 165.7 30.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.319 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -76.37 115.89 4.56 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.26 -1.141 . . . . 0.0 109.497 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.34 140.39 7.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.543 ' SG ' HG13 ' A' ' 269' ' ' VAL . 10.3 p -59.69 171.32 0.9 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -1.153 . . . . 0.0 109.593 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.48 82.48 1.67 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.314 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.595 HG21 ' CG2' ' A' ' 277' ' ' VAL . 6.6 p -79.76 146.04 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.721 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -129.94 171.07 13.15 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 1.078 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -126.47 161.08 28.75 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 54.2 m -164.68 112.17 1.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.264 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.458 ' HD2' ' OG1' ' A' ' 325' ' ' THR . 5.9 mtp-105 -60.57 120.46 10.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.562 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.63 -92.94 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.62 164.89 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 109.595 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.5 OUTLIER -170.46 153.12 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.486 ' O ' ' NZ ' ' A' ' 319' ' ' LYS . 11.7 p90 -161.21 -169.27 2.27 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 17.0 m -84.13 44.56 1.02 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.102 -0.999 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ASP . . . . . 0.434 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.2 t70 -159.57 -35.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.535 ' HA2' ' CG ' ' A' ' 319' ' ' LYS . . . -170.28 178.82 42.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.907 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 12.6 p90 -144.27 133.02 22.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.144 -1.21 . . . . 0.0 109.924 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -79.53 103.49 9.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.931 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.3 t -81.74 147.46 6.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 108.972 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.7 p -126.87 95.4 4.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.323 -0.861 . . . . 0.0 109.174 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 1.078 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 43.6 m-85 -82.33 129.82 34.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.525 ' HA ' HG23 ' A' ' 312' ' ' THR . 0.7 OUTLIER -108.98 116.2 31.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.084 -1.01 . . . . 0.0 110.032 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.664 HG21 ' CH2' ' A' ' 275' ' ' TRP . 89.5 t -88.19 142.53 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.7 t -154.76 126.65 7.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.453 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.16 -38.49 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.46 166.09 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -1.099 . . . . 0.0 109.456 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.05 -41.28 7.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.179 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.86 70.91 10.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 108.951 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.784 ' CE3' HG23 ' A' ' 277' ' ' VAL . 57.7 p-90 -115.57 173.19 6.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 46.2 m -142.6 105.55 4.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.399 -0.813 . . . . 0.0 109.102 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.784 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.3 t -86.25 96.22 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.339 -0.85 . . . . 0.0 109.813 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -67.23 105.72 1.81 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 108.821 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.53 HD11 ' CZ ' ' A' ' 313' ' ' PHE . 12.6 mt -80.03 143.36 34.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -135.44 92.67 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.293 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -60.01 163.62 4.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.445 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 0.8 OUTLIER -111.02 153.97 24.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.417 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.78 -147.57 14.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 285' ' ' GLN . 6.2 m -89.53 19.6 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -1.14 . . . . 0.0 109.467 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.47 ' OE1' ' CG1' ' A' ' 317' ' ' VAL . 67.7 mt-30 -46.99 173.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.308 -0.87 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.464 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.95 163.21 40.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' A' ' 287' ' ' ILE . 17.7 mm -102.18 108.29 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.827 . . . . 0.0 109.145 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.484 ' HB2' ' SD ' ' A' ' 318' ' ' MET . 7.8 tm0? -83.06 -34.76 26.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.969 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -152.81 171.8 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.193 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.879 ' CB ' HG12 ' A' ' 315' ' ' VAL . 15.2 m -167.82 165.1 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.519 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 29.4 p90 -168.67 170.37 9.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 109.909 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.529 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 1.8 m-20 69.95 4.61 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.784 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.756 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -178.07 148.37 0.5 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.183 -0.948 . . . . 0.0 109.623 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 11.8 m-80 -86.44 100.59 12.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.897 . . . . 0.0 109.308 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 304' ' ' VAL . 3.0 p -114.88 139.71 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 295' ' ' VAL . 1.1 p -160.0 156.03 26.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 109.516 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.521 ' N ' ' HD3' ' A' ' 302' ' ' ARG . . . 176.83 -177.56 48.14 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.7 m -170.39 48.23 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.221 -1.164 . . . . 0.0 109.445 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 300' ' ' SER . . . -164.87 38.99 0.29 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 301' ' ' THR . 0.1 OUTLIER 76.35 13.62 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -1.133 . . . . 0.0 109.493 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 300' ' ' SER . 13.4 p -160.51 143.71 13.43 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.248 -0.908 . . . . 0.0 109.552 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.521 ' HD3' ' N ' ' A' ' 297' ' ' GLY . 10.9 mtt180 -139.37 134.22 32.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 48.8 m -80.37 123.89 28.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.559 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 295' ' ' VAL . 79.5 t -99.3 142.69 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.756 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.9 OUTLIER -128.83 162.98 48.41 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 305' ' ' THR . 35.5 Cg_endo -78.01 133.28 12.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.597 2.198 . . . . 0.0 110.368 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -80.02 -32.47 39.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 148.49 -33.57 1.19 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.8 t -150.72 18.55 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -1.143 . . . . 0.0 109.458 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -120.81 65.17 0.46 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -51.08 -28.67 11.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -1.157 . . . . 0.0 109.478 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 267' ' ' TYR . 66.3 m -101.08 123.92 45.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' A' ' 267' ' ' TYR . 6.3 p90 -109.82 170.91 7.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -149.15 127.67 2.55 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.879 HG12 ' CB ' ' A' ' 290' ' ' SER . 5.9 m -134.13 152.15 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 109.828 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.462 ' HB ' ' OE1' ' A' ' 288' ' ' GLN . 18.9 m -82.22 134.39 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.057 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 85.6 t -107.88 124.95 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 288' ' ' GLN . 0.0 OUTLIER -83.19 95.68 8.2 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.106 -0.996 . . . . 0.0 108.523 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.552 ' HD3' ' CB ' ' A' ' 323' ' ' SER . 11.9 mttt -42.59 -47.13 5.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.458 -0.776 . . . . 0.0 109.836 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 319' ' ' LYS . 93.2 m-20 42.76 43.92 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 92.32 20.65 34.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 13.9 m -160.15 99.99 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -1.182 . . . . 0.0 109.58 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.552 ' CB ' ' HD3' ' A' ' 319' ' ' LYS . 61.5 p -93.29 29.8 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.89 143.49 26.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.146 -0.971 . . . . 0.0 109.482 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.879 HG23 ' HD2' ' A' ' 326' ' ' PRO . 16.2 m -68.47 146.52 97.83 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.879 ' HD2' HG23 ' A' ' 325' ' ' THR . 25.3 Cg_endo -73.25 172.6 15.25 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.249 1.966 . . . . 0.0 110.88 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.53 148.69 24.51 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.651 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -140.46 132.39 27.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 109.623 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -127.63 155.85 43.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 109.722 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.488 ' HB2' HG12 ' A' ' 251' ' ' VAL . 43.9 t -124.22 152.87 42.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.588 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -156.9 164.77 37.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 113.65 -109.38 2.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.277 -1.131 . . . . 0.0 109.526 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 331' ' ' ALA . 1.9 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 107.76 -85.77 0.43 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.491 ' SG ' HG13 ' A' ' 269' ' ' VAL . 5.5 p -137.7 172.79 12.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.202 -1.176 . . . . 0.0 109.545 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.1 t -108.13 82.41 1.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.521 HG21 ' CG2' ' A' ' 277' ' ' VAL . 6.2 p -79.85 146.34 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -130.84 168.14 17.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 1.071 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -129.01 162.97 26.38 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -169.02 115.12 0.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.441 ' CG ' ' OG1' ' A' ' 325' ' ' THR . 6.4 mtm-85 -59.68 119.88 8.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.457 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -101.86 -89.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 1.7 mm-40 -84.06 165.38 18.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -170.41 149.3 3.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.373 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.458 ' O ' ' HE3' ' A' ' 319' ' ' LYS . 13.4 p90 -158.84 -168.32 2.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.419 -0.801 . . . . 0.0 109.038 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t -86.5 47.11 1.43 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.199 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ASP . . . . . 0.444 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.5 t70 -160.23 -37.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 109.957 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 319' ' ' LYS . . . -172.27 171.1 44.03 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.763 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 16.8 p90 -131.58 136.22 47.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.951 -1.323 . . . . 0.0 110.061 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 38.8 t30 -79.34 111.4 15.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.895 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.8 t -92.27 147.08 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.477 -0.764 . . . . 0.0 109.328 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.0 p -128.78 94.28 3.81 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.4 -0.812 . . . . 0.0 109.166 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 1.071 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 37.1 m-85 -81.99 126.73 32.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 312' ' ' THR . 2.6 t -105.7 115.96 31.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.923 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.671 HG11 ' CG ' ' A' ' 275' ' ' TRP . 59.1 t -88.27 145.8 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.507 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.6 m -157.64 126.04 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.9 -38.44 1.75 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.55 167.59 29.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -1.09 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 306' ' ' PRO . 2.0 m -99.55 -41.27 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -85.21 67.6 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 108.913 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.75 ' CE3' HG23 ' A' ' 277' ' ' VAL . 56.2 p-90 -110.16 173.41 6.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.496 -0.752 . . . . 0.0 109.688 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.41 112.9 7.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.75 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.8 t -96.49 101.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.52 106.57 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.908 . . . . 0.0 108.838 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.744 HD11 ' CE1' ' A' ' 313' ' ' PHE . 13.6 mt -80.82 143.01 33.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.838 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -134.73 105.54 6.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.265 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.764 HD12 HG13 ' A' ' 317' ' ' VAL . 3.9 mm? -66.08 171.08 4.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.708 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.474 HD22 ' HA ' ' A' ' 326' ' ' PRO . 1.1 m120 -118.55 153.96 33.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.65 -148.3 9.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 285' ' ' GLN . 19.5 p -80.35 5.65 14.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 109.63 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.463 ' C ' ' CG2' ' A' ' 286' ' ' THR . 75.2 mt-30 -43.88 166.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.65 174.06 15.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 109.529 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.659 HG21 ' CZ ' ' A' ' 302' ' ' ARG . 17.8 mm -94.49 132.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.358 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.449 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 40.1 tt0 -106.83 -36.97 6.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.582 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -164.45 169.96 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.639 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.779 ' CB ' HG12 ' A' ' 315' ' ' VAL . 71.2 p -158.13 166.5 32.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.315 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.563 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 32.0 p90 -167.56 172.09 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 33.5 m-20 63.3 10.87 4.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -178.34 149.2 0.51 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -79.97 100.59 8.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 0.0 109.278 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.738 HG13 HG22 ' A' ' 304' ' ' VAL . 4.6 t -107.59 137.66 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER -160.08 156.42 26.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.515 ' N ' ' HD2' ' A' ' 302' ' ' ARG . . . -179.07 -163.42 30.08 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.45 79.44 0.09 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.197 -1.178 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 148.32 -73.21 0.29 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.448 ' O ' HD23 ' A' ' 281' ' ' LEU . 65.5 m -153.27 -54.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -1.154 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 1.0 OUTLIER -79.51 150.44 31.16 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.227 -0.921 . . . . 0.0 109.673 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.659 ' CZ ' HG21 ' A' ' 287' ' ' ILE . 5.7 mtm180 -140.48 143.63 35.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 89.7 m -90.34 121.78 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.738 HG22 HG13 ' A' ' 295' ' ' VAL . 55.3 t -105.32 145.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.476 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.8 OUTLIER -141.33 154.8 67.67 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.8 Cg_endo -78.12 144.46 21.06 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -93.56 -15.94 24.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.63 4.94 16.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.59 27.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -1.179 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.13 63.62 0.33 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASN . . . . . 0.457 ' HB3' ' HB ' ' A' ' 269' ' ' VAL . 56.5 m-20 -53.25 -31.98 46.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -1.138 . . . . 0.0 109.394 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 267' ' ' TYR . 61.4 m -97.44 123.4 41.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.744 ' CE1' HD11 ' A' ' 279' ' ' LEU . 7.7 p90 -108.08 171.96 7.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.576 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.563 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -148.91 128.79 2.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.779 HG12 ' CB ' ' A' ' 290' ' ' SER . 13.6 m -132.45 159.18 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.9 m -92.84 110.09 21.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.764 HG13 HD12 ' A' ' 281' ' ' LEU . 46.6 t -84.19 127.23 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.461 ' HB3' ' OD1' ' A' ' 320' ' ' ASN . 1.5 mmt -79.75 103.74 9.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 108.75 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.503 ' CG ' ' HA2' ' A' ' 262' ' ' GLY . 32.6 mttt -43.03 -46.91 5.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -0.832 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 318' ' ' MET . 11.4 m-20 43.47 44.46 5.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.203 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 122.87 -51.32 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.443 ' HB3' ' OG1' ' A' ' 324' ' ' THR . 0.4 OUTLIER -138.23 140.45 39.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -1.176 . . . . 0.0 109.896 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.568 ' O ' ' CE1' ' A' ' 263' ' ' PHE . 1.1 p -81.4 6.72 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -36.09 129.14 0.69 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.608 -0.683 . . . . 0.0 111.11 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.798 HG23 ' HD2' ' A' ' 326' ' ' PRO . 21.0 m -69.26 144.12 94.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.798 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.8 Cg_endo -72.62 171.99 16.09 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.15 1.9 . . . . 0.0 111.109 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.77 149.67 23.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.639 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -139.58 131.97 28.48 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.975 -1.078 . . . . 0.0 109.965 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -124.36 156.1 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.53 -0.731 . . . . 0.0 109.369 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 48.9 t -123.97 135.44 53.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.883 . . . . 0.0 109.76 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 247' ' ' THR . . . -125.42 156.82 38.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.314 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -82.89 124.64 6.61 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.27 -1.135 . . . . 0.0 109.52 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -158.57 173.42 35.6 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 11.2 p -59.72 172.07 0.78 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -1.167 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.15 81.72 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.756 HG12 ' HB2' ' A' ' 330' ' ' CYS . 6.2 p -79.27 145.82 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.71 170.6 15.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 1.046 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -118.45 164.49 15.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 109.94 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 18.2 m -167.08 104.46 0.55 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.309 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -57.65 125.17 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.704 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -103.58 -83.08 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.709 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 257' ' ' GLU . 39.0 mm-40 -97.53 168.62 10.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 0.0 109.652 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -170.41 146.62 2.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.425 ' CE2' ' O ' ' A' ' 262' ' ' GLY . 12.4 p90 -155.85 -168.46 2.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 43.0 m -84.19 45.65 1.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 110.065 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ASP . . . . . 0.481 ' OD1' ' CE ' ' A' ' 318' ' ' MET . 2.1 t0 -159.99 -36.84 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 317' ' ' VAL . . . -174.64 170.65 43.8 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.654 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 5.6 p90 -135.43 138.0 42.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.267 . . . . 0.0 109.919 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.559 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 90.5 m-20 -79.68 99.04 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.64 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.876 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.3 t -81.16 147.42 6.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 108.786 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 23.9 p -129.39 94.51 3.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 1.046 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 47.9 m-85 -80.32 130.3 35.09 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.458 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.2 t -110.2 121.62 45.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.074 -1.016 . . . . 0.0 110.189 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 251' ' ' VAL . 79.5 t -99.39 131.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.34 116.64 11.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.81 -38.48 0.99 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.96 165.71 35.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -1.09 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -98.17 -43.08 7.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.171 -0.955 . . . . 0.0 109.212 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -81.12 75.6 8.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.875 . . . . 0.0 108.94 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.723 ' CE3' HG23 ' A' ' 277' ' ' VAL . 48.1 p-90 -119.19 173.65 6.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.85 . . . . 0.0 109.648 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.3 m -140.64 115.08 9.38 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.408 -0.807 . . . . 0.0 108.888 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.723 HG23 ' CE3' ' A' ' 275' ' ' TRP . 77.1 t -104.72 105.88 19.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 9.6 t30 -78.93 119.76 22.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 1.055 HD11 ' CZ ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -101.25 128.94 47.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.139 -0.976 . . . . 0.0 110.303 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -116.87 97.2 5.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 109.01 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.808 ' CD2' HG13 ' A' ' 317' ' ' VAL . 1.1 mp -60.77 171.94 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 110.098 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 0.6 OUTLIER -111.52 164.64 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.604 -179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 48.14 -153.42 1.88 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.4 p -88.04 17.17 5.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.993 ' OE1' HG12 ' A' ' 317' ' ' VAL . 8.3 mt-30 -45.33 171.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.452 ' HA ' ' NH2' ' A' ' 302' ' ' ARG . 1.1 p -152.65 170.39 20.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.844 . . . . 0.0 109.572 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.475 ' CG1' ' HD3' ' A' ' 302' ' ' ARG . 19.3 mm -92.82 121.32 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 7.6 tp-100 -95.94 -35.62 11.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -163.11 166.52 23.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.612 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.752 ' CB ' HG12 ' A' ' 315' ' ' VAL . 96.6 p -156.65 168.44 27.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.382 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 24.6 p90 -169.78 170.31 7.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.699 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 52.0 m-20 61.9 12.19 4.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -178.67 173.82 1.25 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.472 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 15.6 m-80 -107.57 101.25 10.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.33 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 1.088 HG22 HG22 ' A' ' 304' ' ' VAL . 46.1 t -106.36 126.28 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 3.5 p -149.5 154.99 39.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' A' ' 302' ' ' ARG . . . 162.82 -161.62 33.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.42 ' OG ' ' C ' ' A' ' 297' ' ' GLY . 0.7 OUTLIER -170.4 133.97 1.11 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.198 -1.177 . . . . 0.0 109.548 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 108.56 -73.26 0.2 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.49 -51.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -1.167 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 302' ' ' ARG . 67.1 p -79.52 160.58 26.45 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 109.605 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.475 ' HD3' ' CG1' ' A' ' 287' ' ' ILE . 0.6 OUTLIER -154.54 167.51 29.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 97.9 m -117.45 124.65 49.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.374 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 1.088 HG22 HG22 ' A' ' 295' ' ' VAL . 74.5 t -106.53 139.26 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -124.1 162.69 40.14 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.389 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -78.37 135.04 13.07 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.609 2.206 . . . . 0.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.62 -29.04 26.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.03 5.72 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.8 t -153.26 24.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.156 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -139.79 64.99 0.53 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -52.25 -25.41 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -1.168 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 267' ' ' TYR . 94.7 m -106.56 127.15 53.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 1.055 ' CZ ' HD11 ' A' ' 279' ' ' LEU . 8.8 p90 -112.1 172.47 6.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -153.66 132.19 3.51 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.752 HG12 ' CB ' ' A' ' 290' ' ' SER . 5.4 m -140.18 152.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -1.17 . . . . 0.0 109.796 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 13.5 m -81.61 128.19 33.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.993 HG12 ' OE1' ' A' ' 285' ' ' GLN . 58.8 t -100.37 106.07 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.793 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.481 ' CE ' ' OD1' ' A' ' 261' ' ' ASP . 2.0 mmt -60.42 97.57 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.033 -1.042 . . . . 0.0 108.682 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.536 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 30.4 mttt -42.33 -46.32 4.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.699 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 319' ' ' LYS . 28.8 m-20 43.88 46.22 6.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.254 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.35 24.41 51.26 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 285' ' ' GLN . 16.7 t -160.65 97.94 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -1.105 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.536 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 21.2 p -92.95 31.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' THR . . . . . 0.418 HG22 ' OD1' ' A' ' 282' ' ' ASN . 0.8 OUTLIER -90.64 146.37 24.09 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.129 -0.982 . . . . 0.0 109.134 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.827 HG23 ' HD2' ' A' ' 326' ' ' PRO . 18.2 m -69.05 145.61 96.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 108.988 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.827 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.4 Cg_endo -72.56 172.6 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.237 1.958 . . . . 0.0 110.66 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -96.62 159.96 14.65 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -156.67 132.4 9.53 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.843 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -133.18 154.84 50.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.402 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.756 ' HB2' HG12 ' A' ' 251' ' ' VAL . 44.4 t -110.78 148.26 32.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.86 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -160.64 170.88 19.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.463 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 102.87 -113.13 4.47 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.255 -1.144 . . . . 0.0 109.446 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 275' ' ' TRP . 2.6 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.263 0.554 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 34.4 m -121.94 84.3 2.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.271 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 269' ' ' VAL . 3.5 p -79.96 149.2 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -131.48 164.1 26.5 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.927 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -120.01 162.74 18.72 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.399 -0.813 . . . . 0.0 109.899 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 255' ' ' ARG . 15.8 m -169.64 161.69 9.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.252 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.514 ' N ' HG22 ' A' ' 254' ' ' THR . 0.6 OUTLIER -106.69 119.71 40.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.506 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -97.68 -89.84 0.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.829 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -91.75 168.63 11.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.764 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 9.0 tt0 -170.29 148.85 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -157.27 -168.93 2.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.478 -0.764 . . . . 0.0 108.957 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t -84.71 46.05 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.113 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -160.22 -36.33 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.489 ' HA2' ' HG3' ' A' ' 319' ' ' LYS . . . -172.63 171.6 44.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.571 ' CE1' ' HB ' ' A' ' 317' ' ' VAL . 5.9 p90 -134.66 137.2 43.4 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.047 -1.267 . . . . 0.0 109.84 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 77.5 m-20 -79.09 102.16 8.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.877 HG11 ' CE1' ' A' ' 267' ' ' TYR . 4.3 t -78.19 150.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.311 -0.868 . . . . 0.0 108.982 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.2 p -133.5 93.43 3.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 0.927 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 48.8 m-85 -81.32 132.4 35.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.461 ' HA ' HG23 ' A' ' 312' ' ' THR . 6.5 m -111.06 119.63 39.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.015 -1.053 . . . . 0.0 110.319 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.569 HG11 ' CG ' ' A' ' 275' ' ' TRP . 71.7 t -97.93 138.01 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.399 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.8 m -149.49 130.38 14.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 132.1 -37.31 2.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.2 m -150.89 159.85 44.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -97.17 -44.57 6.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 108.995 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -80.22 77.41 6.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 108.834 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.639 ' CE3' HG23 ' A' ' 277' ' ' VAL . 60.0 p-90 -123.75 165.39 17.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 109.544 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 330' ' ' CYS . 86.5 m -135.98 118.19 15.55 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.144 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.639 HG23 ' CE3' ' A' ' 275' ' ' TRP . 44.8 t -105.16 104.48 17.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.67 109.36 8.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 108.96 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 313' ' ' PHE . 11.8 mt -79.93 145.97 32.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.65 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.7 96.14 3.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.943 ' CD1' HG13 ' A' ' 317' ' ' VAL . 3.9 mm? -59.89 169.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.551 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.7 OUTLIER -115.57 148.54 39.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.26 -143.61 40.93 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.5 p -84.13 7.94 17.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.598 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.494 ' O ' HG22 ' A' ' 286' ' ' THR . 61.8 mt-30 -44.26 167.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 285' ' ' GLN . 1.1 p -155.89 174.89 14.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.541 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.653 HD11 HD21 ' A' ' 281' ' ' LEU . 13.9 mm -98.59 109.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 0.3 OUTLIER -85.56 -34.23 21.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -165.45 171.36 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 109.831 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 1.016 ' CB ' HG12 ' A' ' 315' ' ' VAL . 43.5 p -161.86 169.98 20.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.347 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 32.1 p90 -169.99 165.91 9.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.3 m-20 71.79 3.42 4.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 109.68 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -174.42 145.66 0.99 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.49 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.65 101.25 12.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.423 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.895 ' HB ' HG22 ' A' ' 304' ' ' VAL . 3.4 p -116.96 141.84 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.583 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . 0.424 ' C ' ' HG2' ' A' ' 302' ' ' ARG . 19.4 p . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 121.274 0.559 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.424 ' HG2' ' C ' ' A' ' 301' ' ' THR . 4.2 mmt180 -139.03 132.24 29.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 295' ' ' VAL . 41.3 m -76.29 118.63 19.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.952 . . . . 0.0 109.503 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.895 HG22 ' HB ' ' A' ' 295' ' ' VAL . 75.6 t -101.59 149.35 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.506 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 1.2 p -146.15 148.36 34.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -77.91 138.64 16.79 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.588 2.192 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.98 -17.91 51.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.13 -37.15 1.43 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.21 11.06 3.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.129 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -109.93 65.14 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 7.1 m120 -58.63 -28.32 65.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -1.163 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.867 HG23 ' O ' ' A' ' 267' ' ' TYR . 88.6 m -102.01 125.58 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.702 ' CE1' HD11 ' A' ' 279' ' ' LEU . 7.0 p90 -111.47 171.46 7.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -151.34 128.68 2.64 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 1.016 HG12 ' CB ' ' A' ' 290' ' ' SER . 17.9 m -133.83 158.19 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.58 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.2 m -88.87 109.22 20.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.943 HG13 ' CD1' ' A' ' 281' ' ' LEU . 25.2 t -79.5 106.6 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 1.1 mmt -59.31 94.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.125 -0.985 . . . . 0.0 108.75 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.539 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 21.2 mttt -41.07 -45.29 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.718 . . . . 0.0 109.775 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 319' ' ' LYS . 55.0 m-20 41.06 45.4 2.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.511 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.61 29.96 28.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 319' ' ' LYS . 29.0 t -160.05 110.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -1.15 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.539 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 11.5 p -98.93 25.44 6.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.69 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . 0.551 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.92 145.72 24.5 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.113 -0.992 . . . . 0.0 109.572 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.847 HG23 ' HD2' ' A' ' 326' ' ' PRO . 16.3 m -71.14 146.47 92.52 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.847 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.9 Cg_endo -73.42 173.37 13.92 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.169 1.913 . . . . 0.0 110.761 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.65 149.25 24.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.552 ' HB3' ' CE2' ' A' ' 267' ' ' TYR . . . -142.43 132.89 25.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.079 -1.013 . . . . 0.0 109.864 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -128.74 156.63 43.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.494 -0.753 . . . . 0.0 109.29 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 22.8 t -131.87 162.84 29.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.96 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.13 179.85 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.521 ' SG ' HG13 ' A' ' 269' ' ' VAL . 9.6 p . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.363 0.601 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.82 81.16 1.62 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.616 HG21 HG21 ' A' ' 277' ' ' VAL . 7.3 p -79.58 149.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.88 171.39 14.47 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 1.116 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -127.99 164.91 21.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -168.55 107.06 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.451 ' HG2' ' OG1' ' A' ' 325' ' ' THR . 1.3 mmm180 -48.97 123.39 7.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -105.41 -90.38 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.706 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 4.3 mm-40 -88.03 165.62 15.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 109.549 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 84.6 tt0 -170.35 155.82 5.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . 0.441 ' N ' ' HG2' ' A' ' 258' ' ' GLU . 11.7 p90 -163.01 -168.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 t -84.34 43.33 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.2 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 319' ' ' LYS . 3.1 t70 -155.68 -38.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.783 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.482 ' O ' ' HE3' ' A' ' 319' ' ' LYS . . . -167.92 -169.08 30.96 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.563 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 31.9 p90 -152.21 128.67 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -1.235 . . . . 0.0 109.894 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 10.0 t30 -79.59 113.18 17.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.82 . . . . 0.0 109.608 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.927 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -92.09 148.16 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 0.0 109.111 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 23.1 p -126.77 95.36 4.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.354 -0.841 . . . . 0.0 109.246 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 1.116 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 42.4 m-85 -80.99 130.84 35.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 108.765 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.456 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.3 p -109.17 119.55 39.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.082 -1.012 . . . . 0.0 110.022 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.642 HG11 ' CD1' ' A' ' 275' ' ' TRP . 79.2 t -92.85 135.62 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.52 116.08 7.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 149.12 -39.17 0.94 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.12 168.58 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -1.118 . . . . 0.0 109.42 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -42.13 7.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.891 . . . . 0.0 109.23 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.64 71.41 10.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 108.868 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.75 ' CE3' HG23 ' A' ' 277' ' ' VAL . 56.7 p-90 -115.81 172.4 7.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 0.0 109.656 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 83.6 m -141.36 108.54 5.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.313 -0.867 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.75 HG23 ' CE3' ' A' ' 275' ' ' TRP . 46.7 t -91.63 103.29 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.354 -0.841 . . . . 0.0 109.906 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.17 111.23 8.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 108.904 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.691 HD23 ' CG2' ' A' ' 304' ' ' VAL . 3.9 mm? -80.09 145.93 32.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.845 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.81 92.53 2.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.221 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.706 HD13 ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -59.93 165.62 3.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.567 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.562 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.6 OUTLIER -110.33 150.65 28.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 56.81 -128.42 46.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.3 m -112.04 30.13 7.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.746 ' OE1' HG12 ' A' ' 317' ' ' VAL . 9.8 mt-30 -62.75 171.83 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.895 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.1 p -149.83 177.04 10.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.491 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.548 HG13 ' CD ' ' A' ' 302' ' ' ARG . 10.1 mm -103.59 131.19 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.281 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.532 ' HG3' ' CG ' ' A' ' 318' ' ' MET . 0.1 OUTLIER -103.41 -38.75 7.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.467 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 315' ' ' VAL . . . -154.63 164.81 38.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.804 ' CB ' HG12 ' A' ' 315' ' ' VAL . 14.6 m -158.13 164.01 37.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.501 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 31.2 p90 -166.74 165.47 16.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.4 m-20 71.7 3.39 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -175.74 148.29 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.154 -0.966 . . . . 0.0 109.592 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.466 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 38.7 m-80 -84.29 101.87 12.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 304' ' ' VAL . 25.7 t -104.37 133.62 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.578 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 302' ' ' ARG . 5.1 p . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 302' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 121.337 0.589 . . . . 0.0 109.572 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.548 ' CD ' HG13 ' A' ' 287' ' ' ILE . 45.5 mtt85 -156.09 168.93 25.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 22.9 m -121.59 121.3 37.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 295' ' ' VAL . 70.8 t -106.68 142.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.521 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.603 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.8 OUTLIER -129.71 160.33 65.3 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.421 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.5 Cg_endo -78.21 131.22 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.61 2.207 . . . . 0.0 110.347 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.01 -25.65 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.08 -42.27 1.06 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.35 11.48 2.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.495 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -110.24 65.33 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 70.3 m-20 -54.94 -24.21 22.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -1.174 . . . . 0.0 109.49 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 267' ' ' TYR . 87.6 m -106.56 124.08 49.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.653 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 7.4 p90 -109.92 172.22 6.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.556 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -151.62 129.51 2.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.804 HG12 ' CB ' ' A' ' 290' ' ' SER . 7.1 m -135.84 157.04 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -1.123 . . . . 0.0 109.656 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 14.6 m -89.74 107.24 18.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.33 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.746 HG12 ' OE1' ' A' ' 285' ' ' GLN . 22.2 t -79.58 106.7 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.701 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.532 ' CG ' ' HG3' ' A' ' 288' ' ' GLN . 0.2 OUTLIER -59.56 108.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.12 -0.988 . . . . 0.0 108.787 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.551 ' HG2' ' CA ' ' A' ' 323' ' ' SER . 4.6 mttm -43.63 -51.31 7.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 45.98 47.02 12.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 78.56 24.08 63.59 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.6 OUTLIER -161.16 102.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -1.118 . . . . 0.0 109.473 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.551 ' CA ' ' HG2' ' A' ' 319' ' ' LYS . 80.0 p -98.11 27.91 4.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.965 . . . . 0.0 109.707 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . 0.562 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.5 141.93 28.25 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.162 -0.962 . . . . 0.0 109.109 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.811 HG23 ' HD2' ' A' ' 326' ' ' PRO . 20.1 m -64.46 144.77 98.6 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.005 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.8 Cg_endo -73.73 173.32 14.14 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.328 2.019 . . . . 0.0 110.882 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.85 148.67 24.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.632 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -141.0 132.64 27.17 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.106 -0.996 . . . . 0.0 109.819 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -126.87 155.77 42.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.393 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . 0.545 ' HB2' HG12 ' A' ' 251' ' ' VAL . 49.3 t -122.91 149.91 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.319 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.543 ' SG ' HG13 ' A' ' 269' ' ' VAL . 10.3 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.329 0.585 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.48 82.48 1.67 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.314 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.595 HG21 ' CG2' ' A' ' 277' ' ' VAL . 6.6 p -79.76 146.04 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.721 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -129.94 171.07 13.15 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 1.078 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -126.47 161.08 28.75 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 54.2 m -164.68 112.17 1.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.264 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.458 ' HD2' ' OG1' ' A' ' 325' ' ' THR . 5.9 mtp-105 -60.57 120.46 10.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.562 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.63 -92.94 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.62 164.89 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 109.595 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.5 OUTLIER -170.46 153.12 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . 0.486 ' O ' ' NZ ' ' A' ' 319' ' ' LYS . 11.7 p90 -161.21 -169.27 2.27 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 17.0 m -84.13 44.56 1.02 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.102 -0.999 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . 0.434 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.2 t70 -159.57 -35.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.535 ' HA2' ' CG ' ' A' ' 319' ' ' LYS . . . -170.28 178.82 42.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.907 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 12.6 p90 -144.27 133.02 22.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.144 -1.21 . . . . 0.0 109.924 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -79.53 103.49 9.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.931 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.3 t -81.74 147.46 6.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 108.972 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.7 p -126.87 95.4 4.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.323 -0.861 . . . . 0.0 109.174 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 1.078 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 43.6 m-85 -82.33 129.82 34.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.525 ' HA ' HG23 ' A' ' 312' ' ' THR . 0.7 OUTLIER -108.98 116.2 31.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.084 -1.01 . . . . 0.0 110.032 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.664 HG21 ' CH2' ' A' ' 275' ' ' TRP . 89.5 t -88.19 142.53 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.7 t -154.76 126.65 7.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.453 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.16 -38.49 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.46 166.09 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -1.099 . . . . 0.0 109.456 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.05 -41.28 7.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.179 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.86 70.91 10.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 108.951 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.784 ' CE3' HG23 ' A' ' 277' ' ' VAL . 57.7 p-90 -115.57 173.19 6.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 46.2 m -142.6 105.55 4.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.399 -0.813 . . . . 0.0 109.102 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.784 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.3 t -86.25 96.22 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.339 -0.85 . . . . 0.0 109.813 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.23 105.72 1.81 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 108.821 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.53 HD11 ' CZ ' ' A' ' 313' ' ' PHE . 12.6 mt -80.03 143.36 34.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -135.44 92.67 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.293 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -60.01 163.62 4.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.554 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.7 OUTLIER -111.02 153.97 24.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.417 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.78 -147.57 14.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 285' ' ' GLN . 6.2 m -89.53 19.6 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -1.14 . . . . 0.0 109.467 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.47 ' OE1' ' CG1' ' A' ' 317' ' ' VAL . 67.7 mt-30 -46.99 173.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.308 -0.87 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.464 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.95 163.21 40.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 287' ' ' ILE . 17.7 mm -102.18 108.29 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.827 . . . . 0.0 109.145 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.484 ' HB2' ' SD ' ' A' ' 318' ' ' MET . 7.8 tm0? -83.06 -34.76 26.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.969 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -152.81 171.8 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.193 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.879 ' CB ' HG12 ' A' ' 315' ' ' VAL . 15.2 m -167.82 165.1 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.519 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 29.4 p90 -168.67 170.37 9.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 109.909 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.529 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 1.8 m-20 69.95 4.61 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.784 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.756 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -178.07 148.37 0.5 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.183 -0.948 . . . . 0.0 109.623 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 11.8 m-80 -86.44 100.59 12.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.897 . . . . 0.0 109.308 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 304' ' ' VAL . 3.0 p -114.88 139.71 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 295' ' ' VAL . 1.1 p . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 109.516 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 121.28 0.562 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.418 ' HB3' ' C ' ' A' ' 296' ' ' THR . 10.9 mtt180 -139.37 134.22 32.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 48.8 m -80.37 123.89 28.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.559 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 295' ' ' VAL . 79.5 t -99.3 142.69 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.756 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.9 OUTLIER -128.83 162.98 48.41 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 305' ' ' THR . 35.5 Cg_endo -78.01 133.28 12.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.597 2.198 . . . . 0.0 110.368 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -80.02 -32.47 39.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 148.49 -33.57 1.19 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.8 t -150.72 18.55 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -1.143 . . . . 0.0 109.458 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -120.81 65.17 0.46 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.08 -28.67 11.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -1.157 . . . . 0.0 109.478 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 267' ' ' TYR . 66.3 m -101.08 123.92 45.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' A' ' 267' ' ' TYR . 6.3 p90 -109.82 170.91 7.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -149.15 127.67 2.55 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.879 HG12 ' CB ' ' A' ' 290' ' ' SER . 5.9 m -134.13 152.15 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 109.828 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.462 ' HB ' ' OE1' ' A' ' 288' ' ' GLN . 18.9 m -82.22 134.39 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.057 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 85.6 t -107.88 124.95 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 288' ' ' GLN . 0.0 OUTLIER -83.19 95.68 8.2 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.106 -0.996 . . . . 0.0 108.523 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.552 ' HD3' ' CB ' ' A' ' 323' ' ' SER . 11.9 mttt -42.59 -47.13 5.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.458 -0.776 . . . . 0.0 109.836 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 319' ' ' LYS . 93.2 m-20 42.76 43.92 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 92.32 20.65 34.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 13.9 m -160.15 99.99 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -1.182 . . . . 0.0 109.58 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.552 ' CB ' ' HD3' ' A' ' 319' ' ' LYS . 61.5 p -93.29 29.8 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . 0.554 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.89 143.49 26.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.146 -0.971 . . . . 0.0 109.482 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.879 HG23 ' HD2' ' A' ' 326' ' ' PRO . 16.2 m -68.47 146.52 97.83 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.879 ' HD2' HG23 ' A' ' 325' ' ' THR . 25.3 Cg_endo -73.25 172.6 15.25 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.249 1.966 . . . . 0.0 110.88 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.53 148.69 24.51 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.651 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -140.46 132.39 27.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 109.623 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -127.63 155.85 43.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 109.722 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . 0.488 ' HB2' HG12 ' A' ' 251' ' ' VAL . 43.9 t -124.22 152.87 42.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.588 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.491 ' SG ' HG13 ' A' ' 269' ' ' VAL . 5.5 p . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.362 0.601 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.1 t -108.13 82.41 1.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.521 HG21 ' CG2' ' A' ' 277' ' ' VAL . 6.2 p -79.85 146.34 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -130.84 168.14 17.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 1.071 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -129.01 162.97 26.38 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -169.02 115.12 0.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.441 ' CG ' ' OG1' ' A' ' 325' ' ' THR . 6.4 mtm-85 -59.68 119.88 8.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.457 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -101.86 -89.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 1.7 mm-40 -84.06 165.38 18.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -170.41 149.3 3.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.373 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . 0.458 ' O ' ' HE3' ' A' ' 319' ' ' LYS . 13.4 p90 -158.84 -168.32 2.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.419 -0.801 . . . . 0.0 109.038 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t -86.5 47.11 1.43 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.199 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . 0.444 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.5 t70 -160.23 -37.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 109.957 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 319' ' ' LYS . . . -172.27 171.1 44.03 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.763 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 16.8 p90 -131.58 136.22 47.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.951 -1.323 . . . . 0.0 110.061 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 38.8 t30 -79.34 111.4 15.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.895 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.8 t -92.27 147.08 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.477 -0.764 . . . . 0.0 109.328 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.0 p -128.78 94.28 3.81 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.4 -0.812 . . . . 0.0 109.166 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 1.071 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 37.1 m-85 -81.99 126.73 32.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 312' ' ' THR . 2.6 t -105.7 115.96 31.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.923 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.671 HG11 ' CG ' ' A' ' 275' ' ' TRP . 59.1 t -88.27 145.8 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.507 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.6 m -157.64 126.04 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.9 -38.44 1.75 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.55 167.59 29.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -1.09 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 306' ' ' PRO . 2.0 m -99.55 -41.27 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -85.21 67.6 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 108.913 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.75 ' CE3' HG23 ' A' ' 277' ' ' VAL . 56.2 p-90 -110.16 173.41 6.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.496 -0.752 . . . . 0.0 109.688 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.41 112.9 7.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.75 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.8 t -96.49 101.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.52 106.57 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.908 . . . . 0.0 108.838 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.744 HD11 ' CE1' ' A' ' 313' ' ' PHE . 13.6 mt -80.82 143.01 33.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.838 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -134.73 105.54 6.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.265 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.764 HD12 HG13 ' A' ' 317' ' ' VAL . 3.9 mm? -66.08 171.08 4.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.708 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 285' ' ' GLN . 1.7 m-80 -118.55 153.96 33.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.65 -148.3 9.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 285' ' ' GLN . 19.5 p -80.35 5.65 14.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 109.63 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.463 ' C ' ' CG2' ' A' ' 286' ' ' THR . 75.2 mt-30 -43.88 166.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.65 174.06 15.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 109.529 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.659 HG21 ' CZ ' ' A' ' 302' ' ' ARG . 17.8 mm -94.49 132.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.358 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.449 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 40.1 tt0 -106.83 -36.97 6.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.582 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -164.45 169.96 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.639 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.779 ' CB ' HG12 ' A' ' 315' ' ' VAL . 71.2 p -158.13 166.5 32.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.315 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.563 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 32.0 p90 -167.56 172.09 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 33.5 m-20 63.3 10.87 4.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -178.34 149.2 0.51 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -79.97 100.59 8.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 0.0 109.278 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.738 HG13 HG22 ' A' ' 304' ' ' VAL . 4.6 t -107.59 137.66 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.244 0.545 . . . . 0.0 109.673 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.659 ' CZ ' HG21 ' A' ' 287' ' ' ILE . 5.7 mtm180 -140.48 143.63 35.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 89.7 m -90.34 121.78 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.738 HG22 HG13 ' A' ' 295' ' ' VAL . 55.3 t -105.32 145.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.476 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.8 OUTLIER -141.33 154.8 67.67 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.8 Cg_endo -78.12 144.46 21.06 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 307' ' ' ASN . 3.5 p30 -93.56 -15.94 24.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.63 4.94 16.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.59 27.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -1.179 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.13 63.62 0.33 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.457 ' HB3' ' HB ' ' A' ' 269' ' ' VAL . 56.5 m-20 -53.25 -31.98 46.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -1.138 . . . . 0.0 109.394 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 267' ' ' TYR . 61.4 m -97.44 123.4 41.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.744 ' CE1' HD11 ' A' ' 279' ' ' LEU . 7.7 p90 -108.08 171.96 7.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.576 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.563 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -148.91 128.79 2.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.779 HG12 ' CB ' ' A' ' 290' ' ' SER . 13.6 m -132.45 159.18 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.9 m -92.84 110.09 21.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.764 HG13 HD12 ' A' ' 281' ' ' LEU . 46.6 t -84.19 127.23 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.461 ' HB3' ' OD1' ' A' ' 320' ' ' ASN . 1.5 mmt -79.75 103.74 9.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 108.75 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.503 ' CG ' ' HA2' ' A' ' 262' ' ' GLY . 32.6 mttt -43.03 -46.91 5.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -0.832 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 318' ' ' MET . 11.4 m-20 43.47 44.46 5.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.203 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 122.87 -51.32 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . 0.443 ' HB3' ' OG1' ' A' ' 324' ' ' THR . 0.4 OUTLIER -138.23 140.45 39.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -1.176 . . . . 0.0 109.896 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.568 ' O ' ' CE1' ' A' ' 263' ' ' PHE . 1.1 p -81.4 6.72 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -36.09 129.14 0.69 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.608 -0.683 . . . . 0.0 111.11 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.798 HG23 ' HD2' ' A' ' 326' ' ' PRO . 21.0 m -69.26 144.12 94.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.798 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.8 Cg_endo -72.62 171.99 16.09 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.15 1.9 . . . . 0.0 111.109 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.77 149.67 23.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.639 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -139.58 131.97 28.48 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.975 -1.078 . . . . 0.0 109.965 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -124.36 156.1 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.53 -0.731 . . . . 0.0 109.369 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 48.9 t -123.97 135.44 53.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.883 . . . . 0.0 109.76 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.314 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 11.2 p . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.271 0.558 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.15 81.72 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.756 HG12 ' HB2' ' A' ' 330' ' ' CYS . 6.2 p -79.27 145.82 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.71 170.6 15.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 1.046 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -118.45 164.49 15.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 109.94 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 18.2 m -167.08 104.46 0.55 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.309 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -57.65 125.17 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.704 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -103.58 -83.08 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.709 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 257' ' ' GLU . 39.0 mm-40 -97.53 168.62 10.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 0.0 109.652 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -170.41 146.62 2.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . 0.425 ' CE2' ' O ' ' A' ' 262' ' ' GLY . 12.4 p90 -155.85 -168.46 2.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 43.0 m -84.19 45.65 1.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 110.065 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . 0.481 ' OD1' ' CE ' ' A' ' 318' ' ' MET . 2.1 t0 -159.99 -36.84 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 317' ' ' VAL . . . -174.64 170.65 43.8 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.654 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 5.6 p90 -135.43 138.0 42.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.267 . . . . 0.0 109.919 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.559 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 90.5 m-20 -79.68 99.04 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.64 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.876 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.3 t -81.16 147.42 6.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 108.786 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 23.9 p -129.39 94.51 3.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 1.046 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 47.9 m-85 -80.32 130.3 35.09 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.458 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.2 t -110.2 121.62 45.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.074 -1.016 . . . . 0.0 110.189 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 251' ' ' VAL . 79.5 t -99.39 131.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.34 116.64 11.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.81 -38.48 0.99 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.96 165.71 35.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -1.09 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -98.17 -43.08 7.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.171 -0.955 . . . . 0.0 109.212 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -81.12 75.6 8.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.875 . . . . 0.0 108.94 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.723 ' CE3' HG23 ' A' ' 277' ' ' VAL . 48.1 p-90 -119.19 173.65 6.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.85 . . . . 0.0 109.648 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.3 m -140.64 115.08 9.38 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.408 -0.807 . . . . 0.0 108.888 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.723 HG23 ' CE3' ' A' ' 275' ' ' TRP . 77.1 t -104.72 105.88 19.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 9.6 t30 -78.93 119.76 22.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 1.055 HD11 ' CZ ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -101.25 128.94 47.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.139 -0.976 . . . . 0.0 110.303 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -116.87 97.2 5.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 109.01 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.808 ' CD2' HG13 ' A' ' 317' ' ' VAL . 1.1 mp -60.77 171.94 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 110.098 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.578 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.3 OUTLIER -111.52 164.64 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.604 -179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 48.14 -153.42 1.88 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.4 p -88.04 17.17 5.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.993 ' OE1' HG12 ' A' ' 317' ' ' VAL . 8.3 mt-30 -45.33 171.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.452 ' HA ' ' NH2' ' A' ' 302' ' ' ARG . 1.1 p -152.65 170.39 20.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.844 . . . . 0.0 109.572 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.475 ' CG1' ' HD3' ' A' ' 302' ' ' ARG . 19.3 mm -92.82 121.32 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 7.6 tp-100 -95.94 -35.62 11.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -163.11 166.52 23.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.612 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.752 ' CB ' HG12 ' A' ' 315' ' ' VAL . 96.6 p -156.65 168.44 27.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.382 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 24.6 p90 -169.78 170.31 7.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.699 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 52.0 m-20 61.9 12.19 4.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -178.67 173.82 1.25 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.472 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 15.6 m-80 -107.57 101.25 10.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.33 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 1.088 HG22 HG22 ' A' ' 304' ' ' VAL . 46.1 t -106.36 126.28 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 302' ' ' ARG . 67.1 p . . . . . 0 N--CA 1.483 1.206 0 CA-C-O 121.189 0.519 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.475 ' HD3' ' CG1' ' A' ' 287' ' ' ILE . 0.6 OUTLIER -154.54 167.51 29.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 97.9 m -117.45 124.65 49.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.374 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 1.088 HG22 HG22 ' A' ' 295' ' ' VAL . 74.5 t -106.53 139.26 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -124.1 162.69 40.14 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.389 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -78.37 135.04 13.07 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.609 2.206 . . . . 0.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.62 -29.04 26.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.03 5.72 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.8 t -153.26 24.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.156 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -139.79 64.99 0.53 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.25 -25.41 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -1.168 . . . . 0.0 109.453 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 267' ' ' TYR . 94.7 m -106.56 127.15 53.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 1.055 ' CZ ' HD11 ' A' ' 279' ' ' LEU . 8.8 p90 -112.1 172.47 6.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -153.66 132.19 3.51 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.752 HG12 ' CB ' ' A' ' 290' ' ' SER . 5.4 m -140.18 152.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -1.17 . . . . 0.0 109.796 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 13.5 m -81.61 128.19 33.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.993 HG12 ' OE1' ' A' ' 285' ' ' GLN . 58.8 t -100.37 106.07 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.793 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.481 ' CE ' ' OD1' ' A' ' 261' ' ' ASP . 2.0 mmt -60.42 97.57 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.033 -1.042 . . . . 0.0 108.682 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.536 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 30.4 mttt -42.33 -46.32 4.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.699 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 319' ' ' LYS . 28.8 m-20 43.88 46.22 6.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.254 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.35 24.41 51.26 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 285' ' ' GLN . 16.7 t -160.65 97.94 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -1.105 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.536 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 21.2 p -92.95 31.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . 0.578 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.8 OUTLIER -90.64 146.37 24.09 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.129 -0.982 . . . . 0.0 109.134 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.827 HG23 ' HD2' ' A' ' 326' ' ' PRO . 18.2 m -69.05 145.61 96.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 108.988 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.827 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.4 Cg_endo -72.56 172.6 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.237 1.958 . . . . 0.0 110.66 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -96.62 159.96 14.65 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -156.67 132.4 9.53 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.843 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -133.18 154.84 50.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.402 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . 0.756 ' HB2' HG12 ' A' ' 251' ' ' VAL . 44.4 t -110.78 148.26 32.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.86 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.463 -179.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -171.51 99.36 0.14 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 275' ' ' TRP . 2.6 p -59.87 147.55 38.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -1.144 . . . . 0.0 109.53 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 34.4 m -121.94 84.3 2.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.271 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 269' ' ' VAL . 3.5 p -79.96 149.2 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -131.48 164.1 26.5 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.927 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -120.01 162.74 18.72 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.399 -0.813 . . . . 0.0 109.899 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 255' ' ' ARG . 15.8 m -169.64 161.69 9.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.252 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.514 ' N ' HG22 ' A' ' 254' ' ' THR . 0.6 OUTLIER -106.69 119.71 40.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.506 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -97.68 -89.84 0.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.829 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -91.75 168.63 11.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.006 . . . . 0.0 109.764 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 9.0 tt0 -170.29 148.85 3.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -157.27 -168.93 2.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.478 -0.764 . . . . 0.0 108.957 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.2 t -84.71 46.05 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.113 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -160.22 -36.33 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.145 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.489 ' HA2' ' HG3' ' A' ' 319' ' ' LYS . . . -172.63 171.6 44.44 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.571 ' CE1' ' HB ' ' A' ' 317' ' ' VAL . 5.9 p90 -134.66 137.2 43.4 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.047 -1.267 . . . . 0.0 109.84 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 77.5 m-20 -79.09 102.16 8.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.877 HG11 ' CE1' ' A' ' 267' ' ' TYR . 4.3 t -78.19 150.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.311 -0.868 . . . . 0.0 108.982 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 15.2 p -133.5 93.43 3.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 0.927 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 48.8 m-85 -81.32 132.4 35.33 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.461 ' HA ' HG23 ' A' ' 312' ' ' THR . 6.5 m -111.06 119.63 39.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.015 -1.053 . . . . 0.0 110.319 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.569 HG11 ' CG ' ' A' ' 275' ' ' TRP . 71.7 t -97.93 138.01 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.399 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.8 m -149.49 130.38 14.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 132.1 -37.31 2.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.2 m -150.89 159.85 44.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -97.17 -44.57 6.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 108.995 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -80.22 77.41 6.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 108.834 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.639 ' CE3' HG23 ' A' ' 277' ' ' VAL . 60.0 p-90 -123.75 165.39 17.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 109.544 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 330' ' ' CYS . 86.5 m -135.98 118.19 15.55 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.144 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.639 HG23 ' CE3' ' A' ' 275' ' ' TRP . 44.8 t -105.16 104.48 17.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.67 109.36 8.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 108.96 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 313' ' ' PHE . 11.8 mt -79.93 145.97 32.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.65 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.7 96.14 3.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.943 ' CD1' HG13 ' A' ' 317' ' ' VAL . 3.9 mm? -59.89 169.56 1.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.551 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.7 OUTLIER -115.57 148.54 39.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 57.26 -143.61 40.93 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.5 p -84.13 7.94 17.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.598 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.494 ' O ' HG22 ' A' ' 286' ' ' THR . 61.8 mt-30 -44.26 167.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 285' ' ' GLN . 1.1 p -155.89 174.89 14.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.541 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.653 HD11 HD21 ' A' ' 281' ' ' LEU . 13.9 mm -98.59 109.62 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 0.3 OUTLIER -85.56 -34.23 21.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.686 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -165.45 171.36 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 109.831 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 1.016 ' CB ' HG12 ' A' ' 315' ' ' VAL . 43.5 p -161.86 169.98 20.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.347 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 32.1 p90 -169.99 165.91 9.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.3 m-20 71.79 3.42 4.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 109.68 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -174.42 145.66 0.99 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.49 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.65 101.25 12.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.423 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.895 ' HB ' HG22 ' A' ' 304' ' ' VAL . 3.4 p -116.96 141.84 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.388 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER -160.15 170.8 20.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.583 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 302' ' ' ARG . . . 168.22 -163.92 37.57 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.48 49.39 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.227 -1.161 . . . . 0.0 109.508 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -167.1 -114.64 0.3 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 301' ' ' THR . 2.7 m -117.8 20.66 13.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -1.16 . . . . 0.0 109.417 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 300' ' ' SER . 19.4 p -160.61 156.11 25.14 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.535 ' HD3' ' CA ' ' A' ' 297' ' ' GLY . 4.2 mmt180 -139.03 132.24 29.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 295' ' ' VAL . 41.3 m -76.29 118.63 19.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.952 . . . . 0.0 109.503 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.895 HG22 ' HB ' ' A' ' 295' ' ' VAL . 75.6 t -101.59 149.35 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.506 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 1.2 p -146.15 148.36 34.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -77.91 138.64 16.79 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.588 2.192 . . . . 0.0 110.445 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -79.98 -17.91 51.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.13 -37.15 1.43 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.21 11.06 3.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.129 . . . . 0.0 109.472 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -109.93 65.14 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 7.1 m120 -58.63 -28.32 65.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -1.163 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.867 HG23 ' O ' ' A' ' 267' ' ' TYR . 88.6 m -102.01 125.58 48.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.702 ' CE1' HD11 ' A' ' 279' ' ' LEU . 7.0 p90 -111.47 171.46 7.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -151.34 128.68 2.64 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 1.016 HG12 ' CB ' ' A' ' 290' ' ' SER . 17.9 m -133.83 158.19 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.58 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.2 m -88.87 109.22 20.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.943 HG13 ' CD1' ' A' ' 281' ' ' LEU . 25.2 t -79.5 106.6 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 1.1 mmt -59.31 94.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.125 -0.985 . . . . 0.0 108.75 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.539 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 21.2 mttt -41.07 -45.29 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.718 . . . . 0.0 109.775 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 319' ' ' LYS . 55.0 m-20 41.06 45.4 2.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.511 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.61 29.96 28.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 319' ' ' LYS . 29.0 t -160.05 110.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -1.15 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.539 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 11.5 p -98.93 25.44 6.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 109.69 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.551 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.92 145.72 24.5 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.113 -0.992 . . . . 0.0 109.572 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.847 HG23 ' HD2' ' A' ' 326' ' ' PRO . 16.3 m -71.14 146.47 92.52 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.847 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.9 Cg_endo -73.42 173.37 13.92 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.169 1.913 . . . . 0.0 110.761 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -101.65 149.25 24.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.552 ' HB3' ' CE2' ' A' ' 267' ' ' TYR . . . -142.43 132.89 25.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.079 -1.013 . . . . 0.0 109.864 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -128.74 156.63 43.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.494 -0.753 . . . . 0.0 109.29 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 22.8 t -131.87 162.84 29.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.96 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -149.69 149.89 31.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.13 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -81.57 111.13 3.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.336 -1.097 . . . . 0.0 109.498 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.437 ' C ' ' HA ' ' A' ' 331' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -162.9 -129.71 1.05 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.521 ' SG ' HG13 ' A' ' 269' ' ' VAL . 9.6 p -60.3 171.74 0.98 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.247 -1.149 . . . . 0.0 109.544 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.82 81.16 1.62 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.302 -0.874 . . . . 0.0 109.166 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.616 HG21 HG21 ' A' ' 277' ' ' VAL . 7.3 p -79.58 149.19 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.88 171.39 14.47 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 1.116 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -127.99 164.91 21.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -168.55 107.06 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.451 ' HG2' ' OG1' ' A' ' 325' ' ' THR . 1.3 mmm180 -48.97 123.39 7.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -105.41 -90.38 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.706 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 4.3 mm-40 -88.03 165.62 15.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 109.549 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 84.6 tt0 -170.35 155.82 5.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.147 -0.971 . . . . 0.0 110.29 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.441 ' N ' ' HG2' ' A' ' 258' ' ' GLU . 11.7 p90 -163.01 -168.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 t -84.34 43.33 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.2 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 319' ' ' LYS . 3.1 t70 -155.68 -38.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.783 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.482 ' O ' ' HE3' ' A' ' 319' ' ' LYS . . . -167.92 -169.08 30.96 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.563 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 31.9 p90 -152.21 128.67 10.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -1.235 . . . . 0.0 109.894 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 10.0 t30 -79.59 113.18 17.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.387 -0.82 . . . . 0.0 109.608 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.927 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -92.09 148.16 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 0.0 109.111 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 23.1 p -126.77 95.36 4.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.354 -0.841 . . . . 0.0 109.246 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 1.116 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 42.4 m-85 -80.99 130.84 35.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 108.765 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.456 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.3 p -109.17 119.55 39.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.082 -1.012 . . . . 0.0 110.022 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.642 HG11 ' CD1' ' A' ' 275' ' ' TRP . 79.2 t -92.85 135.62 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.52 116.08 7.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 149.12 -39.17 0.94 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.12 168.58 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -1.118 . . . . 0.0 109.42 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -42.13 7.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.891 . . . . 0.0 109.23 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.64 71.41 10.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 108.868 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.75 ' CE3' HG23 ' A' ' 277' ' ' VAL . 56.7 p-90 -115.81 172.4 7.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 0.0 109.656 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 83.6 m -141.36 108.54 5.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.313 -0.867 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.75 HG23 ' CE3' ' A' ' 275' ' ' TRP . 46.7 t -91.63 103.29 14.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.354 -0.841 . . . . 0.0 109.906 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.17 111.23 8.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 108.904 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.691 HD23 ' CG2' ' A' ' 304' ' ' VAL . 3.9 mm? -80.09 145.93 32.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.845 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.81 92.53 2.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.221 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.706 HD13 ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -59.93 165.62 3.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.567 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.562 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.6 OUTLIER -110.33 150.65 28.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 56.81 -128.42 46.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.3 m -112.04 30.13 7.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.746 ' OE1' HG12 ' A' ' 317' ' ' VAL . 9.8 mt-30 -62.75 171.83 1.92 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.895 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.1 p -149.83 177.04 10.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.491 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.548 HG13 ' CD ' ' A' ' 302' ' ' ARG . 10.1 mm -103.59 131.19 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.281 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.532 ' HG3' ' CG ' ' A' ' 318' ' ' MET . 0.1 OUTLIER -103.41 -38.75 7.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.467 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 315' ' ' VAL . . . -154.63 164.81 38.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.804 ' CB ' HG12 ' A' ' 315' ' ' VAL . 14.6 m -158.13 164.01 37.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 0.0 109.383 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.501 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 31.2 p90 -166.74 165.47 16.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 1.4 m-20 71.7 3.39 4.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -175.74 148.29 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.154 -0.966 . . . . 0.0 109.592 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.466 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 38.7 m-80 -84.29 101.87 12.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.348 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 304' ' ' VAL . 25.7 t -104.37 133.62 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.578 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 302' ' ' ARG . 5.1 p -112.9 153.83 27.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.479 ' HA2' ' NE ' ' A' ' 302' ' ' ARG . . . -93.48 163.43 26.22 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.54 58.59 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.301 -1.117 . . . . 0.0 109.419 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.42 -91.21 1.45 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.63 -48.92 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -1.134 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 302' ' ' ARG . 0.8 OUTLIER -79.53 172.77 13.34 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.548 ' CD ' HG13 ' A' ' 287' ' ' ILE . 45.5 mtt85 -156.09 168.93 25.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.511 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 22.9 m -121.59 121.3 37.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 295' ' ' VAL . 70.8 t -106.68 142.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.521 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.603 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.8 OUTLIER -129.71 160.33 65.3 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.421 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.5 Cg_endo -78.21 131.22 10.64 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.61 2.207 . . . . 0.0 110.347 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.01 -25.65 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.451 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 144.08 -42.27 1.06 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.35 11.48 2.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.495 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -110.24 65.33 0.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 269' ' ' VAL . 70.3 m-20 -54.94 -24.21 22.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -1.174 . . . . 0.0 109.49 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 267' ' ' TYR . 87.6 m -106.56 124.08 49.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.653 ' CZ ' ' CD1' ' A' ' 267' ' ' TYR . 7.4 p90 -109.92 172.22 6.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.556 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -151.62 129.51 2.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.804 HG12 ' CB ' ' A' ' 290' ' ' SER . 7.1 m -135.84 157.04 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -1.123 . . . . 0.0 109.656 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 14.6 m -89.74 107.24 18.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 109.33 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.746 HG12 ' OE1' ' A' ' 285' ' ' GLN . 22.2 t -79.58 106.7 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.959 . . . . 0.0 109.701 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.532 ' CG ' ' HG3' ' A' ' 288' ' ' GLN . 0.2 OUTLIER -59.56 108.44 0.73 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.12 -0.988 . . . . 0.0 108.787 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.551 ' HG2' ' CA ' ' A' ' 323' ' ' SER . 4.6 mttm -43.63 -51.31 7.06 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 45.98 47.02 12.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 78.56 24.08 63.59 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.6 OUTLIER -161.16 102.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -1.118 . . . . 0.0 109.473 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.551 ' CA ' ' HG2' ' A' ' 319' ' ' LYS . 80.0 p -98.11 27.91 4.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.965 . . . . 0.0 109.707 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.562 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.5 141.93 28.25 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.162 -0.962 . . . . 0.0 109.109 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.811 HG23 ' HD2' ' A' ' 326' ' ' PRO . 20.1 m -64.46 144.77 98.6 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.005 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.8 Cg_endo -73.73 173.32 14.14 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.328 2.019 . . . . 0.0 110.882 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.85 148.67 24.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.632 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -141.0 132.64 27.17 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.106 -0.996 . . . . 0.0 109.819 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -126.87 155.77 42.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.393 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.545 ' HB2' HG12 ' A' ' 251' ' ' VAL . 49.3 t -122.91 149.91 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.747 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.437 ' HA ' ' C ' ' A' ' 247' ' ' THR . . . -149.03 165.7 30.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.319 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -76.37 115.89 4.56 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.26 -1.141 . . . . 0.0 109.497 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.34 140.39 7.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.543 ' SG ' HG13 ' A' ' 269' ' ' VAL . 10.3 p -59.69 171.32 0.9 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -1.153 . . . . 0.0 109.593 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.48 82.48 1.67 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.314 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.595 HG21 ' CG2' ' A' ' 277' ' ' VAL . 6.6 p -79.76 146.04 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.721 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -129.94 171.07 13.15 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 1.078 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -126.47 161.08 28.75 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 109.819 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 54.2 m -164.68 112.17 1.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.264 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.458 ' HD2' ' OG1' ' A' ' 325' ' ' THR . 5.9 mtp-105 -60.57 120.46 10.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.562 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.63 -92.94 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.62 164.89 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 109.595 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.5 OUTLIER -170.46 153.12 4.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.26 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.486 ' O ' ' NZ ' ' A' ' 319' ' ' LYS . 11.7 p90 -161.21 -169.27 2.27 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 17.0 m -84.13 44.56 1.02 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.102 -0.999 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . 0.434 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.2 t70 -159.57 -35.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 110.289 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.535 ' HA2' ' CG ' ' A' ' 319' ' ' LYS . . . -170.28 178.82 42.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.907 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 12.6 p90 -144.27 133.02 22.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.144 -1.21 . . . . 0.0 109.924 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -79.53 103.49 9.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.931 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.3 t -81.74 147.46 6.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 108.972 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.7 p -126.87 95.4 4.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.323 -0.861 . . . . 0.0 109.174 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 1.078 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 43.6 m-85 -82.33 129.82 34.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.525 ' HA ' HG23 ' A' ' 312' ' ' THR . 0.7 OUTLIER -108.98 116.2 31.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.084 -1.01 . . . . 0.0 110.032 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.664 HG21 ' CH2' ' A' ' 275' ' ' TRP . 89.5 t -88.19 142.53 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.7 t -154.76 126.65 7.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.453 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.16 -38.49 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.46 166.09 34.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -1.099 . . . . 0.0 109.456 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.05 -41.28 7.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.179 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -83.86 70.91 10.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 108.951 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.784 ' CE3' HG23 ' A' ' 277' ' ' VAL . 57.7 p-90 -115.57 173.19 6.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 46.2 m -142.6 105.55 4.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.399 -0.813 . . . . 0.0 109.102 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.784 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.3 t -86.25 96.22 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.339 -0.85 . . . . 0.0 109.813 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.23 105.72 1.81 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.19 -0.944 . . . . 0.0 108.821 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.53 HD11 ' CZ ' ' A' ' 313' ' ' PHE . 12.6 mt -80.03 143.36 34.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -135.44 92.67 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.293 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 326' ' ' PRO . 3.9 mm? -60.01 163.62 4.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.573 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.554 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.7 OUTLIER -111.02 153.97 24.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.417 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.78 -147.57 14.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 285' ' ' GLN . 6.2 m -89.53 19.6 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -1.14 . . . . 0.0 109.467 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.47 ' OE1' ' CG1' ' A' ' 317' ' ' VAL . 67.7 mt-30 -46.99 173.37 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.308 -0.87 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.464 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.95 163.21 40.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 287' ' ' ILE . 17.7 mm -102.18 108.29 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.827 . . . . 0.0 109.145 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.484 ' HB2' ' SD ' ' A' ' 318' ' ' MET . 7.8 tm0? -83.06 -34.76 26.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.969 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -152.81 171.8 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 0.0 110.193 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.879 ' CB ' HG12 ' A' ' 315' ' ' VAL . 15.2 m -167.82 165.1 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.519 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 29.4 p90 -168.67 170.37 9.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.041 -1.037 . . . . 0.0 109.909 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.529 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 1.8 m-20 69.95 4.61 4.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.784 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.756 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -178.07 148.37 0.5 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.183 -0.948 . . . . 0.0 109.623 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 11.8 m-80 -86.44 100.59 12.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.897 . . . . 0.0 109.308 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 304' ' ' VAL . 3.0 p -114.88 139.71 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 295' ' ' VAL . 1.1 p -160.0 156.03 26.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.893 . . . . 0.0 109.516 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.521 ' N ' ' HD3' ' A' ' 302' ' ' ARG . . . 176.83 -177.56 48.14 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 5.7 m -170.39 48.23 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.221 -1.164 . . . . 0.0 109.445 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 300' ' ' SER . . . -164.87 38.99 0.29 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 301' ' ' THR . 0.1 OUTLIER 76.35 13.62 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -1.133 . . . . 0.0 109.493 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 300' ' ' SER . 13.4 p -160.51 143.71 13.43 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.248 -0.908 . . . . 0.0 109.552 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.521 ' HD3' ' N ' ' A' ' 297' ' ' GLY . 10.9 mtt180 -139.37 134.22 32.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.395 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 48.8 m -80.37 123.89 28.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.559 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 295' ' ' VAL . 79.5 t -99.3 142.69 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.756 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.9 OUTLIER -128.83 162.98 48.41 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 305' ' ' THR . 35.5 Cg_endo -78.01 133.28 12.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.597 2.198 . . . . 0.0 110.368 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -80.02 -32.47 39.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 148.49 -33.57 1.19 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.8 t -150.72 18.55 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -1.143 . . . . 0.0 109.458 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -120.81 65.17 0.46 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.08 -28.67 11.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -1.157 . . . . 0.0 109.478 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 267' ' ' TYR . 66.3 m -101.08 123.92 45.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' A' ' 267' ' ' TYR . 6.3 p90 -109.82 170.91 7.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -149.15 127.67 2.55 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.879 HG12 ' CB ' ' A' ' 290' ' ' SER . 5.9 m -134.13 152.15 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -1.168 . . . . 0.0 109.828 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.462 ' HB ' ' OE1' ' A' ' 288' ' ' GLN . 18.9 m -82.22 134.39 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.378 -0.826 . . . . 0.0 109.057 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 85.6 t -107.88 124.95 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 288' ' ' GLN . 0.0 OUTLIER -83.19 95.68 8.2 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.106 -0.996 . . . . 0.0 108.523 179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.552 ' HD3' ' CB ' ' A' ' 323' ' ' SER . 11.9 mttt -42.59 -47.13 5.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.458 -0.776 . . . . 0.0 109.836 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 319' ' ' LYS . 93.2 m-20 42.76 43.92 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.36 -0.838 . . . . 0.0 109.446 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 92.32 20.65 34.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 13.9 m -160.15 99.99 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -1.182 . . . . 0.0 109.58 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.552 ' CB ' ' HD3' ' A' ' 319' ' ' LYS . 61.5 p -93.29 29.8 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.554 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.7 OUTLIER -90.89 143.49 26.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.146 -0.971 . . . . 0.0 109.482 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.879 HG23 ' HD2' ' A' ' 326' ' ' PRO . 16.2 m -68.47 146.52 97.83 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.879 ' HD2' HG23 ' A' ' 325' ' ' THR . 25.3 Cg_endo -73.25 172.6 15.25 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.249 1.966 . . . . 0.0 110.88 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -100.53 148.69 24.51 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.651 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -140.46 132.39 27.67 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 109.623 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -127.63 155.85 43.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 109.722 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.488 ' HB2' HG12 ' A' ' 251' ' ' VAL . 43.9 t -124.22 152.87 42.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.588 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -156.9 164.77 37.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 113.65 -109.38 2.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.277 -1.131 . . . . 0.0 109.526 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 331' ' ' ALA . 1.9 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 107.76 -85.77 0.43 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.491 ' SG ' HG13 ' A' ' 269' ' ' VAL . 5.5 p -137.7 172.79 12.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.202 -1.176 . . . . 0.0 109.545 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.1 t -108.13 82.41 1.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.327 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.521 HG21 ' CG2' ' A' ' 277' ' ' VAL . 6.2 p -79.85 146.34 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -130.84 168.14 17.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 1.071 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -129.01 162.97 26.38 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.0 m -169.02 115.12 0.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.441 ' CG ' ' OG1' ' A' ' 325' ' ' THR . 6.4 mtm-85 -59.68 119.88 8.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.457 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -101.86 -89.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 1.7 mm-40 -84.06 165.38 18.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -170.41 149.3 3.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.162 -0.961 . . . . 0.0 110.373 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.458 ' O ' ' HE3' ' A' ' 319' ' ' LYS . 13.4 p90 -158.84 -168.32 2.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.419 -0.801 . . . . 0.0 109.038 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 t -86.5 47.11 1.43 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.073 -1.017 . . . . 0.0 110.199 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . 0.444 ' C ' ' HG3' ' A' ' 319' ' ' LYS . 1.5 t70 -160.23 -37.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 109.957 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.503 ' HA2' ' CG ' ' A' ' 319' ' ' LYS . . . -172.27 171.1 44.03 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.763 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 16.8 p90 -131.58 136.22 47.62 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.951 -1.323 . . . . 0.0 110.061 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 257' ' ' GLU . 38.8 t30 -79.34 111.4 15.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.895 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.8 t -92.27 147.08 5.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.477 -0.764 . . . . 0.0 109.328 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.0 p -128.78 94.28 3.81 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.4 -0.812 . . . . 0.0 109.166 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 1.071 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 37.1 m-85 -81.99 126.73 32.3 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.485 ' HA ' HG23 ' A' ' 312' ' ' THR . 2.6 t -105.7 115.96 31.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 0.0 109.923 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.671 HG11 ' CG ' ' A' ' 275' ' ' TRP . 59.1 t -88.27 145.8 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.507 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.6 m -157.64 126.04 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 136.9 -38.44 1.75 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.55 167.59 29.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -1.09 . . . . 0.0 109.497 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 306' ' ' PRO . 2.0 m -99.55 -41.27 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -85.21 67.6 10.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 108.913 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.75 ' CE3' HG23 ' A' ' 277' ' ' VAL . 56.2 p-90 -110.16 173.41 6.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.496 -0.752 . . . . 0.0 109.688 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.41 112.9 7.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.75 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.8 t -96.49 101.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.52 106.57 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.908 . . . . 0.0 108.838 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.744 HD11 ' CE1' ' A' ' 313' ' ' PHE . 13.6 mt -80.82 143.01 33.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.838 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -134.73 105.54 6.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.265 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.764 HD12 HG13 ' A' ' 317' ' ' VAL . 3.9 mm? -66.08 171.08 4.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.708 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 285' ' ' GLN . 1.7 m-80 -118.55 153.96 33.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 0.0 109.54 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.65 -148.3 9.86 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 285' ' ' GLN . 19.5 p -80.35 5.65 14.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -1.162 . . . . 0.0 109.63 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.463 ' C ' ' CG2' ' A' ' 286' ' ' THR . 75.2 mt-30 -43.88 166.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -154.65 174.06 15.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 109.529 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.659 HG21 ' CZ ' ' A' ' 302' ' ' ARG . 17.8 mm -94.49 132.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.358 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.449 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 40.1 tt0 -106.83 -36.97 6.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.582 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -164.45 169.96 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.639 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.779 ' CB ' HG12 ' A' ' 315' ' ' VAL . 71.2 p -158.13 166.5 32.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.315 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.563 ' CD2' ' O ' ' A' ' 314' ' ' GLY . 32.0 p90 -167.56 172.09 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.683 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 33.5 m-20 63.3 10.87 4.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 109.797 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -178.34 149.2 0.51 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -79.97 100.59 8.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 0.0 109.278 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.738 HG13 HG22 ' A' ' 304' ' ' VAL . 4.6 t -107.59 137.66 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 295' ' ' VAL . 0.8 OUTLIER -160.08 156.42 26.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.515 ' N ' ' HD2' ' A' ' 302' ' ' ARG . . . -179.07 -163.42 30.08 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.45 79.44 0.09 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.197 -1.178 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 148.32 -73.21 0.29 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.448 ' O ' HD23 ' A' ' 281' ' ' LEU . 65.5 m -153.27 -54.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -1.154 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.454 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 1.0 OUTLIER -79.51 150.44 31.16 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.227 -0.921 . . . . 0.0 109.673 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.659 ' CZ ' HG21 ' A' ' 287' ' ' ILE . 5.7 mtm180 -140.48 143.63 35.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 89.7 m -90.34 121.78 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.738 HG22 HG13 ' A' ' 295' ' ' VAL . 55.3 t -105.32 145.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.476 ' O ' ' HB1' ' A' ' 293' ' ' ALA . 0.8 OUTLIER -141.33 154.8 67.67 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.435 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.8 Cg_endo -78.12 144.46 21.06 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.437 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 307' ' ' ASN . 3.5 p30 -93.56 -15.94 24.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.434 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.63 4.94 16.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.59 27.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -1.179 . . . . 0.0 109.47 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.13 63.62 0.33 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.457 ' HB3' ' HB ' ' A' ' 269' ' ' VAL . 56.5 m-20 -53.25 -31.98 46.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -1.138 . . . . 0.0 109.394 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 267' ' ' TYR . 61.4 m -97.44 123.4 41.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.744 ' CE1' HD11 ' A' ' 279' ' ' LEU . 7.7 p90 -108.08 171.96 7.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.576 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.563 ' O ' ' CD2' ' A' ' 291' ' ' TRP . . . -148.91 128.79 2.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.779 HG12 ' CB ' ' A' ' 290' ' ' SER . 13.6 m -132.45 159.18 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 16.9 m -92.84 110.09 21.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.342 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.764 HG13 HD12 ' A' ' 281' ' ' LEU . 46.6 t -84.19 127.23 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.461 ' HB3' ' OD1' ' A' ' 320' ' ' ASN . 1.5 mmt -79.75 103.74 9.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 108.75 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.503 ' CG ' ' HA2' ' A' ' 262' ' ' GLY . 32.6 mttt -43.03 -46.91 5.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -0.832 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 318' ' ' MET . 11.4 m-20 43.47 44.46 5.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.203 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 122.87 -51.32 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.443 ' HB3' ' OG1' ' A' ' 324' ' ' THR . 0.4 OUTLIER -138.23 140.45 39.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -1.176 . . . . 0.0 109.896 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.568 ' O ' ' CE1' ' A' ' 263' ' ' PHE . 1.1 p -81.4 6.72 13.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.38 -0.825 . . . . 0.0 109.179 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -36.09 129.14 0.69 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.608 -0.683 . . . . 0.0 111.11 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.798 HG23 ' HD2' ' A' ' 326' ' ' PRO . 21.0 m -69.26 144.12 94.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.798 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.8 Cg_endo -72.62 171.99 16.09 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.15 1.9 . . . . 0.0 111.109 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.77 149.67 23.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.639 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -139.58 131.97 28.48 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.975 -1.078 . . . . 0.0 109.965 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -124.36 156.1 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.53 -0.731 . . . . 0.0 109.369 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 48.9 t -123.97 135.44 53.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.883 . . . . 0.0 109.76 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 247' ' ' THR . . . -125.42 156.82 38.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.314 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -82.89 124.64 6.61 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.27 -1.135 . . . . 0.0 109.52 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -158.57 173.42 35.6 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 11.2 p -59.72 172.07 0.78 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -1.167 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.15 81.72 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.756 HG12 ' HB2' ' A' ' 330' ' ' CYS . 6.2 p -79.27 145.82 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 109.754 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -134.71 170.6 15.58 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 1.046 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -118.45 164.49 15.18 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 109.94 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 18.2 m -167.08 104.46 0.55 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.855 . . . . 0.0 109.309 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -57.65 125.17 21.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.704 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -103.58 -83.08 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 109.709 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 257' ' ' GLU . 39.0 mm-40 -97.53 168.62 10.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 0.0 109.652 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -170.41 146.62 2.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.425 ' CE2' ' O ' ' A' ' 262' ' ' GLY . 12.4 p90 -155.85 -168.46 2.79 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 43.0 m -84.19 45.65 1.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 110.065 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . 0.481 ' OD1' ' CE ' ' A' ' 318' ' ' MET . 2.1 t0 -159.99 -36.84 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.98 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 317' ' ' VAL . . . -174.64 170.65 43.8 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.654 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 5.6 p90 -135.43 138.0 42.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.267 . . . . 0.0 109.919 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.559 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 90.5 m-20 -79.68 99.04 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 109.64 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.876 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.3 t -81.16 147.42 6.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 108.786 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 23.9 p -129.39 94.51 3.8 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 1.046 ' CE2' ' HB2' ' A' ' 253' ' ' ALA . 47.9 m-85 -80.32 130.3 35.09 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.458 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 1.2 t -110.2 121.62 45.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.074 -1.016 . . . . 0.0 110.189 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 251' ' ' VAL . 79.5 t -99.39 131.96 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.34 116.64 11.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.81 -38.48 0.99 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.96 165.71 35.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -1.09 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.465 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -98.17 -43.08 7.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.171 -0.955 . . . . 0.0 109.212 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -81.12 75.6 8.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.875 . . . . 0.0 108.94 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.723 ' CE3' HG23 ' A' ' 277' ' ' VAL . 48.1 p-90 -119.19 173.65 6.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.85 . . . . 0.0 109.648 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.3 m -140.64 115.08 9.38 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.408 -0.807 . . . . 0.0 108.888 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.723 HG23 ' CE3' ' A' ' 275' ' ' TRP . 77.1 t -104.72 105.88 19.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.269 -0.894 . . . . 0.0 110.189 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 9.6 t30 -78.93 119.76 22.55 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 1.055 HD11 ' CZ ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -101.25 128.94 47.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.139 -0.976 . . . . 0.0 110.303 -179.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -116.87 97.2 5.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 109.01 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.808 ' CD2' HG13 ' A' ' 317' ' ' VAL . 1.1 mp -60.77 171.94 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 110.098 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.578 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.3 OUTLIER -111.52 164.64 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.604 -179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 48.14 -153.42 1.88 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 285' ' ' GLN . 3.4 p -88.04 17.17 5.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.993 ' OE1' HG12 ' A' ' 317' ' ' VAL . 8.3 mt-30 -45.33 171.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.538 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.452 ' HA ' ' NH2' ' A' ' 302' ' ' ARG . 1.1 p -152.65 170.39 20.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.844 . . . . 0.0 109.572 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.475 ' CG1' ' HD3' ' A' ' 302' ' ' ARG . 19.3 mm -92.82 121.32 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 109.367 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 7.6 tp-100 -95.94 -35.62 11.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -163.11 166.52 23.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.612 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.752 ' CB ' HG12 ' A' ' 315' ' ' VAL . 96.6 p -156.65 168.44 27.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.382 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 24.6 p90 -169.78 170.31 7.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.699 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 313' ' ' PHE . 52.0 m-20 61.9 12.19 4.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -178.67 173.82 1.25 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.472 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 15.6 m-80 -107.57 101.25 10.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.33 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 1.088 HG22 HG22 ' A' ' 304' ' ' VAL . 46.1 t -106.36 126.28 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 3.5 p -149.5 154.99 39.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' A' ' 302' ' ' ARG . . . 162.82 -161.62 33.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.42 ' OG ' ' C ' ' A' ' 297' ' ' GLY . 0.7 OUTLIER -170.4 133.97 1.11 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.198 -1.177 . . . . 0.0 109.548 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 108.56 -73.26 0.2 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.49 -51.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -1.167 . . . . 0.0 109.471 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 302' ' ' ARG . 67.1 p -79.52 160.58 26.45 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.241 -0.912 . . . . 0.0 109.605 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.475 ' HD3' ' CG1' ' A' ' 287' ' ' ILE . 0.6 OUTLIER -154.54 167.51 29.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 97.9 m -117.45 124.65 49.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.374 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 1.088 HG22 HG22 ' A' ' 295' ' ' VAL . 74.5 t -106.53 139.26 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -124.1 162.69 40.14 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.389 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 275' ' ' TRP . 35.6 Cg_endo -78.37 135.04 13.07 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.609 2.206 . . . . 0.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -84.62 -29.04 26.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.03 5.72 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.8 t -153.26 24.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.156 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -139.79 64.99 0.53 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.25 -25.41 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -1.168 . . . . 0.0 109.453 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 267' ' ' TYR . 94.7 m -106.56 127.15 53.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 1.055 ' CZ ' HD11 ' A' ' 279' ' ' LEU . 8.8 p90 -112.1 172.47 6.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -153.66 132.19 3.51 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.752 HG12 ' CB ' ' A' ' 290' ' ' SER . 5.4 m -140.18 152.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -1.17 . . . . 0.0 109.796 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 13.5 m -81.61 128.19 33.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.993 HG12 ' OE1' ' A' ' 285' ' ' GLN . 58.8 t -100.37 106.07 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.793 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.481 ' CE ' ' OD1' ' A' ' 261' ' ' ASP . 2.0 mmt -60.42 97.57 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.033 -1.042 . . . . 0.0 108.682 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.536 ' CE ' ' HB2' ' A' ' 323' ' ' SER . 30.4 mttt -42.33 -46.32 4.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.699 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 319' ' ' LYS . 28.8 m-20 43.88 46.22 6.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.254 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.35 24.41 51.26 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 285' ' ' GLN . 16.7 t -160.65 97.94 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -1.105 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.536 ' HB2' ' CE ' ' A' ' 319' ' ' LYS . 21.2 p -92.95 31.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.578 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.8 OUTLIER -90.64 146.37 24.09 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.129 -0.982 . . . . 0.0 109.134 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.827 HG23 ' HD2' ' A' ' 326' ' ' PRO . 18.2 m -69.05 145.61 96.62 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 108.988 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.827 ' HD2' HG23 ' A' ' 325' ' ' THR . 24.4 Cg_endo -72.56 172.6 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.237 1.958 . . . . 0.0 110.66 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -96.62 159.96 14.65 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 267' ' ' TYR . . . -156.67 132.4 9.53 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.033 -1.042 . . . . 0.0 109.843 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -133.18 154.84 50.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.402 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.756 ' HB2' HG12 ' A' ' 251' ' ' VAL . 44.4 t -110.78 148.26 32.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.86 . . . . 0.0 109.628 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -160.64 170.88 19.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.463 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 102.87 -113.13 4.47 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.255 -1.144 . . . . 0.0 109.446 -179.984 . . . . . . . . 0 0 . 1 stop_ save_